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ABSTRACT 
Kava or ‘Awa, Piper methysticum (G. Forst), is traditionally a social, medical and ceremonial 
drink used in Hawai‘i, across the Pacific, and more recently, as a nutraceutical primarily for the 
treatment of anxiety. This thesis documents two distinct yet related projects on kava biology: 
(1) Identification of physiological effects of kava exposure in cells of the immune system. 
Rationale: The efficacy and possible toxicity of kava may reflect additional biological targets in 
addition to GABA receptors in the CNS. Hypothesis: Immune system cells and their calcium 
signaling channels (e.g. the TRP family that have been shown to react to plant secondary 
metabolites from diverse sources) may be novel targets for kava constituents. If validated, this 
hypothesis would illuminate new understandings of the therapeutic potential of kava, as well as 
the indigenous medicine indications of the drink. Results: Using whole cell patch clamping 
techniques, bulk cell calcium and single cell calcium assays and on the RBL2H3 cell model, we 
demonstrated that kava, as well as non-kava lactone components separated via reversed-phase 
HPLC, were active on these non-CNS cellular targets.  Specifically, whole cell patch clamping 
revealed TRPV1-like, TRPM2-like and ICRAC-like conductances.  Bulk calcium assays showed at 
minimum that some non-kava lactone fractions initiated a minor release of both internal and 
external calcium stores, which was confirmed by single cell calcium assays indicating a 
significant difference (p < 0.01) was observed.  We further characterized calcium responses 
demonstrated by non-fractioned kava extractions via calcium-stored depletion using thapsigargin, 
a known ICRAC inductor, and calcium add-back experiments and learned that kava is able to 
enhance calcium influx responses above those initiated via ICRAC depletion indicating that non-
CRAC channels are being recruited and are not-overlapping.  Conclusions: These results suggest 
that a diverse secondary metabolome in kava is likely to affect the physiological and 
pathophysiological response in cells via compounds other than kavalactones and via targets other 
than GABA-R. Future studies would focus upon identification by fractionation of the individual 
secondary metabolites that are regulating human immune cell calcium signaling pathways. 
 (2) Pilot evaluation of the kava plant associated microbiome. Rationale: Production of these 
secondary metabolites that regulate human physiology are heavily affected by changes in the 
physical and biological environment of the whole plant, including the plant’s associated 
microbial community. The first step towards assessing this impact on kava is to define the soil 
and plant microbiome, so we present the first known kava microbiome study. Hypothesis: The 
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kava plant associated microbiome is different between cultivars and differs from surrounding 
bulk soil. If validated, this hypothesis would form the basis for more extensive studies to assess 
the impact of associate microbiome on kava secondary metabolism. Results: We compared the 
microbial communities associated with two kava strains (Hanakapi‘ai and Papa ‘ele ‘ele) and 
surrounding bulk soil. In addition, since washing of the roots is a key preparative step for 
indigenous kava users, we assessed the impact of this practice on the microbial community 
associated with roots of the Papa kea kava strain. Conclusions: Significant differences were 
observed between bulk soil and strains, but more importantly, significant differences in the 
microbiome between strains were determined. Future studies would focus on larger sample sets 
and replicate samples to archive statistically significant and robust differences, however, these 
data do indicate that cultivars indeed select their microbial ecology and root washing affects the 
microbiome.  
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CHAPTER 1 	
1. INTRODUCTION 
 
 1.1 Background 
 
Piper methysticum G. Forst, meaning, "intoxicating pepper," is a shrub-like plant 
known predominantly as kava, or ‘Awa to the Native Hawai‘ians. It is native to Oceania, 
growing throughout Polynesia, Melanesia, and Micronesia [1]. The plant was 
domesticated ~3000 years ago in Vanuatu, and spread throughout Oceania via 
Austronesian colonists  [2]. In the Native Hawai‘ian culture, ‘Awa is described as coming 
to Hawai‘i with the akua (gods) Kāne and Kanaloa. Kāne is believed to have made water 
appear to nurture the ‘awa crop. 
Traditionally, the consumption of kava as a beverage was sacred in Pacific 
cultures. Indeed, in the words of Mary 
Kawena‘ulaokalaniahi‘iakaikapoliopelekawahine‘aihonuaināleilehuaapele Pukui  
“…..‘Awa was the food of the gods…….no religious ritual was complete without it” [3]. 
Offerings of ‘Awa were made to protect the health of the Hawai‘ian people, in rites of 
passage, to lift tabus and to both facilitate consensus-building and prepare for war or 
battle. Margaret Titcomb [4] summarized usages of ‘Awa: “The ‘Awa custom is of 
interest in Hawai‘i because it was a sacred drink of importance in many phases of 
Hawai‘ian life. … Its effect is to relax mind and body …..  Medical kahunas (learned 
men) had many uses for it…..It was essential on occasions of hospitality and feasting, 
and as the drink of pleasure of the chiefs”. A Hawai‘ian mele illustrating these usages is 
shown at left. 
Various parts and preparations of ‘Awa were used medicinally in Pacific cultures. 
From their earliest contact with Pacific islanders, Europeans were therefore interested in 
kava as a medicine, first as a treatment for venereal diseases [5], and later as a sedative 
and treatment for anxiety [2]. A major boom in kava popularity occurred in the 1990s 
linked to both health-related and recreational usage for non-Pacific audiences. The most 
recent incarnation of the kava story is as a nutraceutical, formulated as pills and liquid 
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extracts, as an analogue to anti-anxiety drugs. Products are standardized to a specified 
concentration of kavalactones (see Figure 1), which have been extracted from kava plant 
material with alcohol, acetone, or water. 
In the contemporary Pacific, people still drink kava. The drink is still prepared in 
a semi-traditional manner as a water extract served from a common bowl into smaller 
drinking cups (often coconut shells). The drinking protocols and associated social 
meanings continue to evolve. There is an awareness of the traditions associated with kava, 
even if little of this knowledge is incorporated into the actual way the beverage is 
consumed.  The purpose of contemporary consumption is largely consonant with less 
formal consumption of earlier times, but the frequency of consumption, amount 
consumed, and social context of kava drinking also reflect modern shifts in perspective 
and social relations. Current exposure is in some cases significantly different from that in 
the past. As such, a review of kava’s safety should examine these shifting and nuanced 
social dynamics, rather than reiterating past dichotomies of traditional/nontraditional 
consumption [6].  
Contemporary kava use presents two distinct patterns of consumption: social and 
nutraceutical. Social kava drinking involves what is assumed to be relatively high doses 
(over a gram a day), with the dosage not strictly controlled or limited.  Whereas kava 
nutraceutical consumption is of a fixed recommended daily dose (~200 mg/day) for the 
goal of treating a specific medical condition (usually anxiety), thus its use is personal 
rather than social.  Traditionally, kava is mixed with water, is not extracted with another 
solvent, is strained by hand, and is prepared as a social drink. By contrast, nontraditional 
nutraceutical forms of kava are solvent-extracted, usually as part of a commercial process, 
and not consumed socially. In fact, extraction methods that differed from traditional 
water methods using solvents such as acetone or ethanol has been shown to be more 
efficiently in removing the kava lactones [6, 7].  Specifically, acetone extractions showed 
a marked increase in total kavalactones with a total percentage 89.5% compared to water 
extraction at 78.5% as well as a far higher percentage of all identified components at 
99.4% vs. 83.7%, respectively [8].  Acetone also somewhat extracted other kavalactones 
not found in water due to their nonpolar nature, while ethanol extractions tended to leave 
out a few additional constituents, most notably flavokawain B [8], which may have anti-
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carcinogenic properties [9, 10] but increased the concentration of certain kava lactones, 
notably yangonin and desmethoxyyangonin [8].  Thus, it should be remembered that 
these two forms are not identical, as they are prepared by substantially different 
techniques, and using different solvents. Second, kava drinking is a social activity, 
whereas supplement consumption is a personal activity with no inherent social dimension. 
Third, kava beverage is not a standardized product, whereas nutraceuticals supposedly 
are.  A full description of traditional kava drinking and nontraditional consumption is 
beyond the scope of this research [2, 6], but there are some salient points for comparison 
when thinking about dosage, effects, and possible risk from these different consumption 
practices. First, the amount of kava consumed by drinkers is significantly higher than that 
consumed by those taking supplements.  Supplement strengths range for 100 to 300 mg 
per dose with extracts varying from 30 to 70% kava lactones; however, most clinical 
studies on which safety and efficacy are based, use 100 mg doses standardized to 70% 
kava lactones [6, 11].  Kava drinkers will normally consume several coconut shells of 
kava beverage in a typical drinking session. On average, each shell contains as much 
more than the recommended daily dose of kavalactones used in supplement form for 
treating anxiety (~200 mg). The consensus of the online kava community, where the 
majority of non-traditional kava users gain their information, suggests that the average 
coconut shell serving of kava contains anywhere from 150 to 500 mg of kava lactones 
with no explanation as to how this concentration was determined; however, Teschke et al. 
reported a concentration of 71.5 mg of kavapyrones (kava lactones) in traditional extract 
made from 10 g of powdered crude kava in 100 mL of water, which calculates to a daily 
dose of 210 mg per 300 mL [12].  A night’s dose of kavalactones from drinking kava (5-
10 shells) could easily be in the range of 1.0-2.5 grams.  This is considered high, even 
according to multiple kava online forums/websites that claim the Kava Committee of the 
American Herbal Products Association (AHPA) recommended no more than 300 mg/day 
and the Federal Drug Administration (FDA) recommendation of 290 mg/day, though 
these claims could not be verified and further sheds light on the challenges of kava safety 
and dosing.  
It is difficult to accurately determine the number of people who are consuming 
kava, the amount of kava they are taking, and the frequency with which they use it; 
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especially since sales and import data is often proprietary [13]. Global use of kava 
supplements was certainly substantially lower than it was in 2001, prior to bans instituted 
by several countries due to concerns about liver toxicity [7, 14-20]. However supplement 
use in the US continues with over 50% of Americans taking some form of dietary 
supplement, while consumption of kava, as a social beverage, seems to be increasing [21-
29].  Data on the amount of kava produced and exported are not accurate, sales figures 
for kava products are not widely available, and it is difficult to estimate number of users 
since both the production and consumption sides of the commodity chain are fragmented.  
However, one kava beverage company, Taki Mai, reported that Fiji earned over $20 
million in kava exports between 2012 and 2014 and estimates the exports to the U.S. 
alone should reach the $15 million estimating over 100 kava bars in existence.  Fiji is so 
sure that the market is growing, that the Ministry of Agriculture initiated the Kava Act of 
2016 as they plan to increase growing of kava to meet the demand with Fiji currently 
producing approximately 4000 tonnes of kava on 1300 hectares.   
Kava is grown in more than six different island nations in the Pacific and in the 
wider Pacific Islander diaspora. It is consumed locally and exported to the United States 
for manufacture into nutraceuticals. Fiji, Vanuatu, Samoa, and Tonga are primary kava-
exporting countries[30]. Export statistics from the producer nations give a partial glimpse 
of consumption, but they are not widely available or reliable. The decentralized, 
minimally regulated nature of kava’s commodity chain contributes to this uncertainty. 
With respect to supplement use, several companies produce kava supplements (and other 
products such as kava skin creams), primarily for the US market. There is the potential 
for this market to dramatically increase, following a 2014 court decision in Germany that 
overturned the ban on kava products in that country. Changes such as this to the 
regulatory frameworks in which kava is embedded could quickly affect the availability of 
these products.  
Kava consumption in the US has expanded through supplement availability and 
most recently through the proliferation in kava bars. In the Pacific, there have also been 
changes in the pattern of kava consumption. Migration within the region has brought 
kava drinking to places where it was not previously a tradition (e.g., Kiribati, New 
Caledonia, the Solomon Islands, and New Zealand; see [6, 31]). In addition, changing 
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social practices in societies for which kava drinking is a tradition may be leading to 
increased consumption. For example, more women are drinking kava in the Pacific than 
in previous decades, as kava consumption in the Pacific was generally considered taboo 
for women.  Though some cultures allowed kava to be served by women, the activity was 
mostly kept separated to include not engaging in sex with women after consuming kava 
[2].  ‘Awa use by women in traditional Hawai‘ian culture is known; however, it was 
mainly allowed by ali‘i class women under rare ceremonial conditions and rarely in the 
presence of men [4, 32].  ‘Awa was even offered to female deities, especially Pele who 
was fond of hiwa and mō ‘ī varieties [32, 33] and is documented in chants to her by 
females of her clan [32].  On the other hand, taboos of ‘Awa use is also represented with 
kapus being placed on females of reproductive age due to concerns of premature birth 
and other negative effects [32, 34].  Overall, the increased acceptance of women drinkers 
in addition to other factors indicate there is more demand for kava for general 
consumption, and more kava consumed in those drinking sessions, as well as an increase 
in growing kava [35]. In light of these points, a review of the potential toxicity of kava is 
timely. 
The known active ingredients in kava are the kavalactones.  Eighteen of these 
have been identified, but only six of them: methysticin, dihydromethysticin, kawain, 
dihydrokawain, desmethoxyyangonin and yangonin, have been the focus of kava studies 
as they make up 96% of organic extracts [36]. See Figure 1. for structures of major kava 
components. However, kava extractions contain a variety of other non-lactone 
compounds, which may be responsible for the pharmacological benefits and potential 
toxicity [8, 36].  The activity of kava may be the result of one of these non-lactone 
compounds or a synergy of several or all components found in kava.  In fact, studies on 
RBL2H3 mast cells (Rat Basophilic Leukemia subtype 2H3, purchased from ATCC® 
CRL-2256), showed that traditional aqueous kava extracts elicited strong calcium 
responses not seen in individual or combined purified kava lactones, specifically 
methysticin, dihydromethysticin and kawain [37]. Furthermore, traditional aqueous kava 
extracts demonstrated mast cell degranulation whereas purified lactones did not [37]. 
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Figure 1. Kava constituents discussed in the text. [38]. 
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Kawain 
MW: 230.26 CAS# 500-64-1 
Methysticin 
MW: 274.27 CAS# 495-85-2  
Desmethoxyyangonin 
MW: 228.24 CAS# 15345-89-8  
Flavokawain A 
MW: 314.33 CAS# 3420-72-2  
Flavokawain B 
MW: 284.31 CAS# 1775-97-9  
Flavokawain C 
MW: 300.31 CAS# 56798-34-6  
5,7-dimethoxyflavanone 
MW: 284.31 CAS# 1036-72-2 
Bornyl cinnamate 
MW: 284.39 CAS# 6330-67-2 
Dihydromethysticin 
MW: 276.28 CAS# 3155-57-5 
Dihydrokawain 
MW: 232.28 CAS# 587-63-3 
Yangonin 
MW: 258.27 CAS# 500-62-9  
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A focus on kavalactones may neglect other important compounds in kava that can 
direct cellular responses. Additional kava components include the dihydrochalcones 
(flavokawains A, B and C), 5,7-dimethoxyflavanone, cinnamic acid bornyl ester as well 
as tentatively identified compounds classified as phenolics, flavanones, fatty acids and a 
chalcone, specifically 2,5,8-trimethyl-1-naphthol, 5-methyl-1phenylhexene-3-yn-5-ol, 
8,11-octadecadienoic acid-methyl ester, 5,7-(OH)2-4’-one-6,8-dimethylflavanone, 7-
dimethoxyflavanone-5-hydroxy-4’ and pinostrobin chalcone [8].  Cinnamic acid has been 
shown to activate the mast cell calcium channel TRPA1 and has been associated with 
contact dermatitis [39-41] while the pinostrobin chalcone can act as a stimulatory or 
inhibitory molecule on mast cells [42]. Equally important, the type of extraction solvent 
used has a marked effect on the ratios of these compounds, as well as the kavalactones, 
with some compounds not being extracted at all [8].   
Though studies have focused on the kavalactones being the primary components 
of kava extractions, correctly since they have demonstrated a mechanistic connection to 
gamma amino butyric acid (GABA) receptors, the chemical complexity of kava extracts 
suggests that a kavalactone-centric approach may (1) underestimate the complexity of 
and (2) not provide a mechanism for some of the non-GABA based medicinal effects.  A 
comprehensive understanding of ‘Awa chemistry is of importance in assessing the future 
of kava exposure in both Pacific and global populations. This generates two key 
considerations. First, the type of extraction to be characterized has important implications. 
There is a tension between fidelity to the traditional aqueous extractions of primarily root 
samples, and the need to analyze organic extracts of aerial and root powders that are the 
major nutraceutical forms of commercialized ‘Awa. There is good evidence that kava 
toxicity and efficacy are linked to extraction method. Since both traditional and 
commercial/organic extracts are public health issues, both need to be examined 
comprehensively.  
Kava plants are likely to contain a diverse secondary metabolome, with hundreds 
of compounds that can impact the physiological responses of human cells and tissues [8, 
36, 43-45].  The focus of the ‘Awa field upon the kavalactones is linked to the strong 
likelihood that these compounds’ ligation of central nervous system (CNS) GABA 
receptors is responsible for the relaxant and anxiolytic effects of the drink and its 
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supplements [46, 47]. However, the physiological (and possibly pathophysiological) 
effects of kava may be underestimated by a unilateral focus upon the kavalactones. The 
secondary metabolome of Cannabis sativa provides an analogy here. For decades the 
primary focus of the field, the marijuana growing community, and medicinal marijuana 
proponents has been on the major cannabinoid compounds Δ9-THC, cannabidiol and 
cannabinol. These are indeed the main CNS-active components but they and their 
derivatives comprise ~7 of the >400 known bioactive molecules in Cannabis sativa. 
Indeed, until the so-called ‘entourage’ of terpenes, alkaloids, etc., was factored into 
cannabinoid pharmacology [48, 49], our understanding of its mechanisms and breadth of 
effect was severely limited. Similarly, the ‘Awa field may now benefit from examination 
of the Piper methysticum ‘entourage’. 
A more in depth published literature review (Contemporary Pacific and Western 
perspectives on ‘Awa (Piper methysticum) toxicology. Showman AF, Baker JD, Linares 
C, Naeole CK, Borris R, Johnston E, Konanui J, Turner H. Fitoterapia. 2015 Jan; 100:56-
67. Review. PMID: 25464054) is located in Appendix I. 
 
 1.2. Why study kava? 
Studying kava gives Western pharmaceutical an opportunity to understand the 
traditional indigenous practice.  These indigenous practices include relaxation, conflict 
resolution, relationship-building, psycho-spiritual/ritual and medicinal uses.  In 
Hawai‘ian culture, native plants like ‘Awa is a part of their family, and the sharing of that 
plant symbolizes a contract between them and their ancestors.  Thus anything said during 
the social practice is contractual and their ancestors make them accountable [50].  
Medicinally, different strains are selected for different uses based on their effects and 
their mana.  For example, nene is used for mind and body relaxation and given to those 
suffering back and muscle pain and to reduce stress while hiwa stains, (meaning black, 
night, magestical), such as Papa ‘ele ‘ele is given to bring intuitive dreams [50].  Western 
use of kava has also been for anxiety and anti-inflammatory conditions, but kava may 
also have anti-carcinogenic benefits. 
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Further investigation into the potential human health issues (possible 
hepatotoxicity, kava dermopathy).  Despite the link to kava and liver toxicity 
demonstrated in vivo and in vitro, in the history of Western kava use, toxicity is still 
considered relatively rare.  Only a fraction of the handful of cases reviewed for liver 
toxicity could be, with any certainty, linked to kava consumption and most of those 
involved the co-ingestion of other medications/supplements [14, 51].  That means the 
incident rate of liver toxicity due to kava is one in 60-125 million patients [18].   For 
Pacific traditional users, despite the much higher kavalactone exposure, ‘Awa liver 
toxicity is either unheard of or unreported. Nevertheless, in rural areas of the Pacific, 
where hepatitis is endemic, liver disease that may be caused by kava consumption may be 
masked and reported as other causes [15].  It is difficult to say with any sense of accuracy 
since there is a shortage of epidemiology and public health data in Pacific populations 
who habitually use kava.  Much of the linked toxicity has been associated with type of 
extract; nutraceutical forms of kava are generally extracted through the use of organic 
solvents such as acetone or alcohol to increase the amount of kava lactones retained.  
Traditionally, water extracts have been used for making of the social and medicinal drink; 
however, alcohol is used in making tinctures from ‘Awa to increase its potency by 
soaking the dried ‘Awa roots from moon to moon in an alcohol concentration of 40% or 
higher.  These tinctures are often used to treat toothaches and other mouth problems [50]. 
Kava is of agro-economic importance in Hawai‘i and the Pacific, and the 
growing community needs scientific support.  With the lifting of the European kava ban 
and increased growth of non-traditional kava drinking establishments in the mainland, 
USA, kava has great potential to become a cash-crop for Hawai‘i, as well as the rest of 
the Pacific islands.  For some time, the economy of Hawai‘i has needed to diversify the 
existing industrial complex that has been bases for generations.  ‘Awa has the potential to 
be this important economic diversification; however, in doing so, it is of importance that 
safety, efficacy and quality control be maintained and these can be supported by the 
scientific community working closely with local growers.   
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 1.3 Kava Knowledge Gaps 
 
We lack a mechanistic understanding of active compounds of kava and what these compounds 
target in the human body, physiological and pathophysiological effects.  Furthermore, we need to 
understand the breadth of bioactive compounds in kava, as the current focus has only been on a 
limited number of kavalactones. Finally, the scientific community has not provided information 
that supports industry in growing and testing (standardization, toxicology, provenance) of kava 
for consumption. 
 
 1.4. Objectives Overview 	
In this work, I hope to (1) identify the physiological effects of kava exposure in cells of the 
immune system and (2) provide the first pilot evaluation of the kava plant associated microbiome. 
 
(1) Identification of physiological effects of kava exposure in cells of the immune 
system. Rationale: The efficacy and possible toxicity of kava may reflect additional 
biological targets in addition to GABA receptors in the CNS. Hypothesis: Immune 
system cells and their calcium signaling channels (e.g. the TRP family that have been 
shown to react to plant secondary metabolites from diverse sources) may be novel targets 
for kava constituents. If validated, this hypothesis would illuminate new understandings 
of the therapeutic potential of kava, as well as the indigenous medicine indications of the 
drink. 
(2) Pilot evaluation of the kava plant associated microbiome. Rationale: Production 
of these secondary metabolites that regulate human physiology are heavily affected by 
changes in the physical and biological environment of the whole plant, including the 
plant’s associated microbial community. The first step towards assessing this impact on 
kava is to define the soil and plant microbiome, so we present the first known kava 
microbiome study. Hypothesis: The kava plant associated microbiome is different 
between cultivars and differs from surrounding bulk soil. If validated, this hypothesis 
would form the basis for more extensive studies to assess the impact of associate 
microbiome on kava secondary metabolism.   
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CHAPTER 2: 
 
2. INTRODUCTION 	
 In this chapter, we suggest that some of the efficacy and toxicity of kava may 
additionally be caused by TRP and ICRAC cellular responses via the influx and efflux of 
calcium ions.  Here, the population based, and single cell (confocal) analysis of kava 
components (crude extracts, LCMS fractions and synthetic compounds) using fluorescent 
calcium-sensitive dyes (Fluo-4) and electrophysiology recordings of calcium-selective 
cation channel were used to determine activity induced by kava extracts, fractions and 
synthetic compounds.  Results suggest that the physiological and pathophysiological 
effects of kava is more complex than just CNS and GABA induced responses by the kava 
lactones and may be the result of secondary kava metabolites.  These findings have been 
published in a peer-reviewed paper, which is reproduced below: 
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Differential	regulation	of	calcium	signalling	pathways	by	components	of	
Piper	methysticum	(‘Awa)	
L.M.N. Shimoda, A. Showman, J. D. Baker, I. Lange, D. L. Koomoa, A. J. 
Stokes, R. P. Borris and H. Turner (2015). Phytother. Res. 29: 582-590. 
 
 2.1. Abstract 
Kava is a soporific, anxiolytic and relaxant in widespread ritual and recreational 
use throughout the Pacific. Traditional uses of kava by indigenous Pacific Island peoples 
reflect a complex pharmacopeia, centered on GABA-ergic effects of the well-
characterized kavalactones. However, peripheral effects of kava suggest active 
components other than the CNS-targeted kavalactones. We have previously shown that 
immunocytes exhibit calcium mobilization in response to traditionally prepared kava 
extracts, and that the kavalactones do not induce these calcium responses. Here, we 
characterize the complex calcium-mobilizing activity of traditionally prepared and 
partially HPLC-purified kava extracts, noting induction of both calcium entry and store 
release pathways. Kava components activate intracellular store depletion of thapsigargin-
sensitive and -insensitive stores that are coupled to the calcium release activated (CRAC) 
current, and cause calcium entry through non-store-operated pathways. Together with the 
pepper-like potency reported by kava users, these studies lead us to hypothesize that kava 
extracts contain one or more ligands for the transient receptor potential (TRP) family of 
ion channels. Indeed, TRP-like conductances are observed in kava-treated cells under 
patch clamp. Thus TRP-mediated cellular effects may be responsible for some of the 
reported pharmacology of kava.  
 2.2. Introduction 
A drink made from varying preparations of ground rhizome and root from Piper 
methysticum plays a key role in Pacific island ritual and social interactions [52-56].  
Variously, the beverages ‘Awa, sakau, ava, kava-kava and yaqona (Hawai‘i, Micronesia, 
Tonga and the Marquesas, Fiji) play a role in traditional decision-making processes, and 
in the building of relationships and consensus in small island contexts [54, 57, 58].  
Contemporary recreational use has outpaced the degree to which traditional practitioners 
can guide kava preparation and cultivation, and has extended kava’s impact to a global 
recreational and nutraceutical audience. This globalization of kava brings new 
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perspectives to its study, placing Western drug discovery and toxicology/efficacy studies 
alongside opportunities to explore the mechanistic bases for kava’s actions in a manner 
informed by indigenous knowledge [1, 15, 19, 59, 60].  
Kava has a broad indigenous pharmacology that encompasses both CNS-centered 
and peripheral effects [61]. The CNS-centered effects of kava are the most highlighted in 
sacramental and ritual kava drinking, recreational use and contemporary nutraceutical 
marketing campaigns. These are the sedative and calming effects which, in the 
nutraceutical industry, are promoted as treatments for stress, anxiety and depression, 
often portrayed as ‘natural’ analogues of anxiolytic and antidepressant pharmaceuticals 
[55, 59, 62]. The candidate bioactive secondary metabolites in kava for these CNS-
centered effects are the kavalactones [46, 58, 60, 63-65]. These compounds include 
kavain, methysticin and dihydromethyisticin (refer to Figure 1.) and are putative ligands 
for GABA receptors [46, 47]. Peripherally, kava (as beverage, root or various plant parts) 
is indicated in traditional Pacific medicine for urogenital conditions (gonorrhoea 
infections, chronic cystitis and difficulty urinating), reproductive and women’s health (for 
menstrual problems and dysmenorrhea, to facilitate delivery, to stimulate milk production, 
its leaves as an abortifacient and contraceptive), gastrointestinal distress, respiratory 
ailments (asthma, coughs and tuberculosis), skin diseases and topical wounds, and as an 
analgesic [54, 55, 57-59]. Significant subtlety and nuance attend the precise strain, plant 
component and preparative method to be used [54, 55, 57-59]. These data suggest active 
components in kava that extend beyond the GABA-ergic kavalactones, and that may be 
sufficiently varying with strain, component and preparative method to underlie the 
complexity that is evident in the traditional pharmacopeia [8, 36, 43-45]. 
The premise of the current study is that the broad peripheral effects of kava, 
together with untapped potential medicinal efficacy and concomitant toxicology concerns, 
create a need to understand the cellular impact of both kavalactones and non-kavalactone 
components of the kava drink [15, 19, 59-61, 66-69]. There have been few reports of the 
cellular signalling pathways regulated by kava components other than kavalactones. Our 
previous studies suggest that at least one major target in peripheral cells is the 
mobilization of intracellular free calcium, a signal of sufficient magnitude and 
complexity to engender complex downstream effects at the organ and tissue level [37]. 
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Moreover, the reported presence of bioactive secondary metabolites in other Piper spp. 
that affect the gating of TRP channels (sensors for compounds such as capsaicin, allicin, 
vanillin, gingerol, cinnamaldehyde, menthol and others) lead us to hypothesize that kava 
may contain TRP-active components. Some of these (e.g. cinnamaldehyde) have been 
reported in kava extracts [8, 70-73]. Here we perform a detailed analysis of the calcium-
mobilizing activity of both raw and fractionated kava extracts, adhering to traditional 
extraction methods informed by Hawai‘ian kūpuna as a basis for starting analytes.  
 2.3. Methods and Materials 
2.3.1. Cell culture:  
RBL2H3 (Rat Basophilic Leukemia cell line subtype 2H3) from ATCC (CRL-2256) [74] 
were grown at 37 °C, 5% CO2, in 95% humidity in Dulbecco’s modified Eagle’s medium 
(Mediatech Inc., Herndon, VA) with 10% heat-inactivated fetal bovine serum 
(Mediatech) and 2mM glutamine. 
2.3.2. Chemicals:  
General chemicals were from VWR (West Chester, PA). Thapsigargin and ionomycin 
were from Calbiochem (Gibbstown, NJ).   
2.3.3. Kava extract purification: 
Powdered kava root was obtained from P. methysticum ‘Awa strains Papa kea, Papa ‘ele 
‘ele and Hanakāpi‘ai grown in Pepe‘ekeo (19°50′12″N 155°6′19″W) Hilo, 
Hawai‘i by Mr. Edward Johnston (Association of Hawai‘ian ‘Awa, August 2013). P. 
methysticum G. Forst voucher specimens are held by the Bishop Museum, Honolulu, 
Hawai‘i. Annotated specimens and germplasm of the Hawai‘ian cultivars traditionally 
named here are documented in the archives of the Association of Hawai‘ian ‘Awa, Hilo, 
Hawai‘i [1]. Roots were harvested, washed (kūpuna Jerry Konanui, Pahoa, HI) and 
ground into a fine paste. Standardized water-based extractions were performed to 
generate a 1% (w/v) suspension, with gentle agitation (magnetic stirrer) for 5 min 
preceding filtration through a fine fabric mesh. This protocol reproduces, as closely as 
possible, the traditional method of extraction that is currently used in the Pacific [1, 37]. 
Commercial dry powder preparations of Mahakea (Hawai‘ian Kava Center, Honolulu, 
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HI) and Kū makua (Maui  ‘Awa Company, Lahaina, HI) were processed similarly. 
Sequential chromatography approaches for commercial ‘Awa extracts generated 8 
subsequent batches of test analyte. Data from sequential fraction of Batch 1 (HPLC 
analysed using Shimadzu Sunrise C18 column, 10 x 2 50 mm, 5 micron particles, eluted 
with acetonitrile:water:formic acid (400:600:1) @ 3 mL/min) are presented here. 
2.3.4. Imaging:  
Bright field and fluorescence imaging of cells in MatTek dishes (50,000 cells per cm2) 
were performed on a Nikon Ti Eclipse C1 epi-fluorescence and confocal microscopy 
system, equipped with a heated stage. Available laser lines in FITC, TxRed and Cy5 were 
supplied by a 488-nm 10-mW solid state laser, a 561-nm 10-mW diode pump solid state 
(DPSS) laser and a 638-nm 10-mW modulated diode laser. Each z disc (optical section) 
was 150 nm. Pinhole size for all images was 60 microns. Images were analysed in NIS 
Elements (Nikon, Melville, NY). 
2.3.5. Calcium assay (bulk method):  
RBL2H3 were washed and incubated with 2.0-µM Fluo-4 for 30 min at 37 °C in a 
standard modified Ringer’s solution of the following composition (in mM): NaCl 145, 
KCl 2.8, CsCl 10, CaCl2 10, MgCl2 2, glucose 10, Hepes·NaOH 10, pH7.4, 330mOsm. 
Cells were transferred to 96-well plates at 50 000 cells/well and stimulated as indicated. 
Calcium signals were acquired using a Flexstation 3 (Molecular Devices, Sunnydale, 
USA). Data was analysed using SoftMax® Pro 5 (Molecular Devices). Where indicated, 
nominally calcium-free external conditions were achieved by the preparation of 0mM 
CaCl2 Ringer solution containing 1mM EGTA. 
2.3.6. Calcium assay (single cell method): 
RBL2H3 were plated on glass coverslip dishes (MatTek, Ashland, MA) and incubated 
with 1-µM Fluo-4 for 30 min at 37 °C in a standard modified Ringer’s solution as 
described above. After washing, cells were stimulated as indicated on a 37 °C heated 
stage. Calcium signals were acquired using a Nikon Ti Eclipse confocal microscopy 
system, using EZ C1 software for acquisition and NIS Elements software (Nikon) for 
analysis. Where indicated, nominally calcium-free external conditions (indicated as ~0 
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mM) were achieved by the preparation of 0 mM added CaCl2 Ringer solution containing 
1mM EGTA.  
2.3.7. Electrophysiology:  
For patch-clamp experiments, cells were grown on cell-culture glass-bottom dishes 
(Cellview, Greiner Bio-One, Germany) and kept in a standard modified Ringer’s solution 
of the following composition (in mM): NaCl 130, CsCl 2.8, CaCl2 20, MgCl2 2, glucose 
11, Hepes·NaOH 10, pH7.3. Intracellular pipette-filling solutions contained (in mM): Cs-
glutamate 140, NaCl 8, MgCl2 3, Cs-BAPTA 10, pH7.3 adjusted with CsOH. In order to 
prevent passive store depletion, CaCl2 was added, and free calcium was clamped to 
~177nM free, calculated using Webmaxc Standard (http://web.stanford.edu/~cpatton/ 
webmaxcS.htm). Agonists were dissolved in the standard extracellular solution, 
containing 10mM calcium. Patch-clamp experiments were performed in the tight-seal 
whole-cell configuration at 21– 25 °C. Current recordings were acquired by patch-clamp 
amplifier system EPC-10-USB (HEKA, Lambrecht, Germany). Glass pipettes had 
resistances between 2.5 and 3.5MΩ after filling with the standard intracellular solution. 
Immediately following establishment of the whole-cell configuration voltage ramps of 
50-ms duration spanning the voltage range of -100 to +100mV were delivered from a 
holding potential of 0mV at a rate of 0.5Hz over a period of 500 to 800 s. All voltages 
were corrected for a liquid junction potential of 10mV between external and internal 
solutions. Currents were filtered at 2.9kHz and digitized at 10-kHz intervals. Capacitive 
currents and series resistance were determined and corrected before each voltage ramp 
using the capacitance compensation of the EPC-10. For analysis, ramps were digitally 
filtered at 2kHz. Currents were normalized to the current obtained before development of 
currents.  
2.3.8. Analysis:   
Results are shown as the mean + standard deviation. Statistical significance was 
determined based on ANOVA or Student’s t-test where appropriate. Adjacent to data 
points in the respective graphs, significant differences were recorded as follows: single 
asterisk, p< 0.05; double asterisk, p< 0.01; triple asterisk, p< 0.001; no symbol, p> 0.05. 
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Experiments are n of 3– 10. Where indicated the integral Area Under the Curve (AUC) 
was calculated using GraphPad Prism. 
 2.4. Results 
2.4.1. Kava extract-induced conductances contain store-operated and TRP-like 
components 
In a previous study we have shown that kava extracts initiate striking elevations in 
intracellular free calcium in a model immune system cell, the RBL2H3 basophil [37, 74]. 
This action on calcium signalling is independent of the kavalactones, commonly viewed 
as the major ‘active’ components of kava [37]. In the current study, we tested the 
hypothesis that kava extracts would include compounds active at members of the TRP 
calcium permeant non-selective cation channel family. RBL2H3 are used here as a 
convenient model system because they co-express a range of calcium entry mechanisms 
including store operated calcium entry via ICRAC, and various TRPs [40, 75-80]. Kava 
extracts from the Hawai‘ian Mahakea strain were applied to RBL2H3 in a single cell, 
whole cell patch clamp configuration. Across the cell population, three discrete kava-
induced conductances were observed. Figure 2. (A and B) shows a TRPV1-like current, 
with a 0-mV reversal potential, attaining inward current amplitudes of > 10 pA/pF. These 
currents were present in approximately 30% of cells assayed. Figure 2. (C and D) shows 
a TRPM2-like current, again developing to large (> 20 pA/pF) magnitudes and reversing 
at 0mV. TRPM2-like currents were observed in approximately 18% of the cells assayed. 
Finally, Figure 2. (E and F) shows the development of a small conductance with the 
distinctive signature associated with ICRAC; developing to 1– 2pA/pF inward amplitude 
and reversing at approximately +40mV. This conductance was also observed in 
approximately 20% of the cells assayed. 
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Figure 2. Whole cell patch clamp analysis of kava extract-induced conductances in 
RBL2H3 cells. 
RBL2H3 were analysed in the whole cell configuration with applied 1% aqueous kava 
extracts (Mahakea) prepared as described and applied in internal solution over the 
indicated time course. Three types of conductance were observed repeatedly in the cell 
population (n=21 cells). Examples of each of these conductance types are shown here. A., 
C., E. Inward and outward current development over time. B., D., F. Current/voltage 
(I/V) relationships. A, B. Development of TRPV-like current after application of kava 
extract (n=7/21). C., D. Development of TRPM-like current after application of kava 
extract (n=2/21). E, F. Development of ICRAC-like current after application of kava extract 
(n=4/21). CRT; control. External solution: 20mM CaCl2, 2mM MgCl2, 130mM NaCl, 
2.8mM CsCl, 10mM NaOH-HEPES, 11mM glucose. Internal solution: 140mM Cs-Glut, 
8mM NaCl, 3mM MgCl2, 10mM CsOH-HEPES, 10mM BAPTA, 4.3mM CaCl2.  	
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2.4.2. Kava extracts prepared in the traditional manner cause calcium influx and 
release from intracellular stores 
We asked whether the Mahakea-induced conductances in Figure 2. translated to 
significant calcium influx responses, and whether store release was involved. Initial 
experiments with complete Mahakea samples suggested that both release and influx 
responses were visible in bulk calcium assays [37]. We fractionated complete extracts 
into 9 sub-fractions, using C18 columns and acetonitrile elution, in order to dissect these 
responses. Figure 3.A. shows that, like complete extracts, early fractions (F1 and F2) 
induce a rapid elevation in intracellular Fluo-4 fluorescence, upon which is super-
imposed a developing calcium influx response that is similar in character to those 
observed with stimuli such as antigen and thapsigargin in these cells. We interpret these 
data such that F1 and F2 may contain autofluorescent compounds that initially artificially 
elevate the baseline (2–10 s after addition) [81] and that a conventional calcium influx 
pathway is then activated. Notably, sub-fractions 3–9 contain calcium-mobilizing activity 
that is not complicated by the presence of significant autofluorescence.  Figure 3.B. 
shows that, in nominally calcium free media, the initial (probably autofluorescence-
based) elevation in signal caused by F1 and F2 is not followed by marked influx. 
However, while some sub-fractions contained an apparent and very minor release 
response (F3–9), the bulk assay system could not definitively address the issue of store 
release.  
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Figure 3. Apparent calcium influx and store release in kava-treated RBL2H3 cells. 
RBL2H3 were loaded with Fluo-4 and assayed in bulk (50,000 cells per well, traces are 
mean of triplicate wells) for kava extract (Mahakea starting material) fraction-induced 
calcium responses. Experiments were performed in 1mM CaCl2 and nominally calcium 
free (~0mM CaCl2 with 1mM EGTA) external solutions (A. and B., respectively). Open 
bar indicates baseline period prior to stimulus addition. Black bar represents period of 
exposure to stimulus. Responses to vehicle (black trace), ionomycin (500 nM, red trace) 
and fractions (F1–9) from the batch 1 (B1) HPLC protocol (HPLC—Shimadzu Sunrise 
C18 column, 10 x 250mm, 5 micron particles, eluted w/acetonitrile:water:formic acid 
(400:600:1) @ 3mL/min), are shown. 
Showman,	Chemical	and	Microbial	Ecology	of	‘Awa,	Piper	methysticum	(G.	Forst)	
	 32	
In Figure 4. we used a single cell calcium imaging assay system to address this 
point. This system is free of the fluorescence artifacts [81] that we note in the bulk assay. 
Figure 4. shows averaged traces from >50 individual cells loaded with Fluo-4 and to 
which Mahakea samples were added using a microapplicator system. In nominally 
calcium free conditions we noted release responses above baseline variations (green 
trace) and the areas under the curve (AUC) calculated for these release responses were 
significantly different (p<0.01) from vehicle-treated cells. These data are definitive for 
the presence of calcium store release-inducing activity in Mahakea samples. 
 
Figure 4. Single cell calcium assay of kava extract-induced release and influx 
responses in RBL2H3.  
Single cell calcium imaging was performed in Fluo-4 loaded cells stimulated with 1% 
aqueous ‘Awa extracts (Mahakea). Black bar represents period of exposure to stimulus. 
Single z discs (150 nm vertical step) were analyzed by drawing a whole cell region of 
interest (ROI) and assessing the whole cell averaged Fluo-4 intensity over time. Green 
trace. Averaged release response to extract from 23 cells in nominally calcium free buffer. 
Violet trace. Averaged release response to vehicle from 23 cells in nominally calcium 
free buffer. Inset: Area under the curve analysis (AUC) for indicated data sets. 
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2.4.3. Kava constituents release calcium from thapsigarginsensitive and -insensitive 
intracellular stores 
We further characterized the influx and release responses induced by Mahakea 
samples. Figure 5.A. shows that influx responses induced by Mahakea samples are not 
additively increasing those induced by thapsigargin (i.e. ICRAC  induction). Calcium add-
back experiments (Figure 5.B.) showed that, at the population level, kava samples were 
able to additively enhance influx responses over and above those initiated by 
thapsigargin-mediated store depletion via ICRAC. Thus kava components are recruiting 
non-CRAC channels. At the level of store release (Figure 5.C.), we noted that depletion 
of thapsigargin sensitive stores did not prevent subsequent release responses initiated by 
Mahakea samples, indicating that these stores are non-overlapping. This was also true 
when stimuli were added in the reciprocal sequence and for Inositol (1,4,5) trisphosphate 
(Ins (1,4,5) P3) sensitive store compartments (not shown). These data suggest that 
intracellular calcium stores sensitive to kava components are not completely overlapping 
with the SERCA or Ins (1,4,5) P3 sensitive stores.   
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Figure 5. Dissection of calcium store release responses induced by kava and the 
SERCA inhibitor Thapsigargin. A–C. 
A–C. RBL2H3 were loaded with Fluo-4 and assayed in bulk (50,000 cells per well, 
traces are mean of triplicate wells) for 1% aqueous kava extract (Mahakea starting 
material) induced calcium responses in 1mM external calcium (A., B.) or nominally 
calcium free conditions (C.). Each experiment had three phases: Open bar represents 
baseline establishment. Black bar represents duration of primary stimulus application. 
Grey bar represents duration of secondary stimulus application. The sequence of 
baseline/primary/secondary stimuli is shown at right of each trace or in legend. 
Thapsigargin and ionomycin were used at 500 nM. B. Calcium add-back experiment 
protocol. Baseline and primary stimulus (1% aqueous kava application, 500-nM 
ionomycin) application were performed in nominally calcium free external conditions 
(open and black bars). Calcium was then resupplied to a concentration of 1mM in the 
third phase of the experiment (grey bar). 	
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2.4.4. Traditionally prepared kava extracts contain chemically separable store-
operated and non-store-operated influx inducing components 
The complete secondary metabolome of kava has not been defined, and it is 
therefore difficult to assign likely candidate molecules to the calcium-mobilizing 
responses described here. As a first step in this process we asked whether: (i) the 
activities that initiate release and influx (of the store-operated and non-store operated 
types) were chemically separable, and (ii) whether different kava chemotypes/cultivars 
displayed differential abilities to mobilize calcium by any of these pathways. Figure 
6.A.–E. shows various Mahakea sub-fractions analysed for their abilities to initiate 
release and influx. These data are summarized within Table 1, which shows that the 
intensity of release and influx responses is chemically separable. Moreover, when we 
differentiated between store-operated and non-store-operated calcium influx (SOCI and 
non-SOCI, i.e. that occurring putatively via ICRAC and TRP-type channels, respectively), 
we saw a further level of differentiation. Non-SOCI was defined as that occurring 
additively to the influx initiated by store depletion using thapsigargin (Figure 5). There 
are also clearly (as in Figure 3) issues with fractions where there may be fluorescence 
background.   
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Figure 6. Fractionation of aqueous kava extracts differentially preserves calcium 
release and influx responses. A–E. 
A–E. RBL2H3 were loaded with Fluo-4 and assayed in bulk (50,000 cells per well, traces 
are mean of triplicate wells) for kava extract (Mahakea starting material) fraction induced 
calcium responses. Experiments were performed in 1mM CaCl2 and nominally calcium 
free (~0mM CaCl2 with 1mM EGTA) external solutions. The latter have been offset from 
the former by ~15 RFU in order to view traces clearly. Open bar indicates baseline period 
prior to stimulus addition. Black bar represents period of exposure to stimulus. Responses 
to vehicle (black trace), ionomycin (500 nM, red trace) and fractions (F4–8) from the 
batch 1 (B1) HPLC protocol (HPLC—Shimadzu Sunrise C18 column, 10 × 250 mm, 5 
micron particles, eluted w/ acetonitrile:water:formic acid (400:600:1) @ 3 mL/min), are 
shown. 
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Table 1. Summary of differential induction of release and influx response intensity 
induced by the indicated B1 fractions in RBL2H3.  
SOCI, store-operated calcium influx (via ICRAC); non-SOCI, nonstore- operated calcium 
influx (TRP and other channels) 
 
Finally, we asked whether aqueous samples prepared using standardized 
methodology from a range of traditional Hawai‘ian cultivars [1] displayed differential 
ability to initiate store release and influx, and SOCI versus non-SOCI. Table 2 
summarizes these data sets. Root powder from the indicated that kava cultivars were 
prepared as described, and calcium release and influx responses were compared. Relative 
intensities between cultivars were calculated by normalizing to the maximal responses 
initiated by addition of the calcium ionophore ionomycin. These data show that the rank 
order of release activity by these criteria is Kū makua > Papa kea > Papa ‘ele ‘ele ≈ 
Mahakea > Hanakāpi‘ai. Rank order of influx responses over all (SOCI + non-SOCI) 
was Hanakāpi‘ai > Papa kea ≈ Kū makua > Papa ‘ele ‘ele > Mahakea. All cultivars 
displayed SOCI but varied strikingly in their ability to induce non-SOCI. Hanakāpi‘ai in 
particular has strong non-SOCI responses. 
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Table 2. Comparison of calcium release and influx responses induced by 15 aqueous 
extracts from various Hawai‘ian ‘Awa cultivars.  
RBL2H3 were loaded with Fluo-4 and assayed in bulk (50,000 cells per well, mean of 
triplicate wells) for kava extracts (1% aqueous solution of ground root powder for the 
indicated cultivars). The comparison columns summarize the relative intensity of release 
and influx responses induced by the 1% extracts. The normalized K/I factor expresses 
each cultivar-induced response as a proportion of the ionomycin-induced response 
(calculated from areas under the curve, n = 3 for each sample). Ionomycin-induced 
release and influx responses would be 1.0. SOCI, store-operated calcium influx (via 
ICRAC); non-SOCI, non-store-operated calcium influx (TRP and other channels). Numbers 
in parentheses represent ratios of maximum response amplitude with Mahakea set as the 
unitary response. 
 
 2.5. Discussion 
Kava plants are likely to contain a diverse secondary metabolome, with hundreds 
of compounds that can impact the physiological responses of human cells and tissues [8, 
36, 43-45]. The focus of the ‘Awa field upon the kavalactones is linked to the strong 
likelihood that these compounds’ ligation of CNS GABA receptors is responsible for the 
relaxant and anxiolytic effects of the drink and its supplements [46, 47]. However, the 
physiological (and possibly pathophysiological) effects of kava may be underestimated 
by a unilateral focus upon the kavalactones. The secondary metabolome of Cannabis 
sativa provides an analogy here. For decades the primary focus of the field, the marijuana 
growing community and medicinal marijuana proponents has been on the major 
cannabinoid compounds Δ9-THC cannabidiol and cannabinol. These are indeed the main 
CNS-active components, but they and their derivatives comprise ~7 of the > 400 known 
bioactive molecules in C. sativa. Indeed, until the so-called ‘entourage’ of terpenes, 
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alkaloids, etc., was factored into cannabinoid pharmacology [48, 49], our understanding 
of its mechanisms and breadth of effect was severely limited. Similarly, the ‘Awa field 
may now benefit from examination of the P. methysticum ‘entourage’. Our current and 
previously published data suggest that effects on intracellular free calcium may provide a 
convenient assay system for assessment of non-kavalactone pharmacology of ‘Awa.   
As in our previous study, the relationship between kavalactones and calcium-
mobilizing activity seems minimal [37]. LeBot assembled a comprehensive analysis of 
kavalactone abundance in air-dried root preparations of individual Hawai‘ian ‘Awa 
cultivars [1, 57, 64].  There is no obvious correlation between the ordering of kavalactone 
abundance in these cultivars and the ordering of their capacity in terms of initiating 
calcium responses. Notably for at least one cultivar (Papa ‘ele ‘ele), this is an inverse 
relationship. It should be noted that, since kavalactones are GABA-ergic and some 
reports suggest that GABA receptors are in mast cells and/or basophils, we examined the 
effect of GABA receptor inhibitors on the kava-induced non-SOCI. Inhibitors of the 
ionotropic and G-protein coupled GABA receptors (saclofen, bicuculline, TPMPA and 
CGP54626) did not affect kava-induced non-SOCI (data not shown).  
A large number of non-kavalactone components have been described for P. 
methysticum, of which multiple secondary metabolites would be within the family of 
compounds known to regulate the TRP channels (cinnemaldehyde, cinnamic acid, 
capasaicin/piperidine and vannilins) [8, 36, 43, 44].  In contrast, we are reduced to 
speculation about likely mechanisms for the manner in which kava components might 
regulate calcium store depletion and SOCI. These putative mechanisms would frame 
further experiments, and are: (i) that the kava samples contain ligands for receptors (e.g. 
Gα q-coupled GPCR) that mobilize Ins (1,4,5) P3 and initiate SOCI in that fashion; (ii) 
the kava samples contain compounds that are SERCA inhibitors. The latter is of 
particular interest when we note that thapsigargin itself is a natural plant product (a 
sesquiterpene lactone from Thapsia garanica L.), and that quinones and gingerol have 
also been shown to regulate SERCA activity [82]. The former model is also plausible, 
since plant odorants, endogenous lipids and cyclic peptides have variously been described 
to ligate GPCR. Recent descriptions of a kavalactone cannabinoid receptor (the GPCR 
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CB1) ligand and the overlap between the cannabinoid receptor ligands and TRP 
pharmacology are intriguing and worthy of further study [83, 84].  
Calcium mobilizing activity is, of course, not only a convenient assay system in 
which to compare fractions, cultivars and extraction methods: as a fundamental second 
messenger, it is a critical mediator of cellular responses including growth, differentiation, 
motility and extensive transcriptional and functional responses. In cells of the immune 
system, of which RBL2H3 exemplify the mast cell/basophil type, calcium signals 
regulate cytokine and chemokine transcription and functional responses such as the 
release of immunological and inflammatory mediators [76, 85].  We have previously 
shown that kava extract-induced calcium signals are sufficient to induce inflammatory 
mediator release and the activation of calcium-dependent transcription factors in 
RBL2H3 [37]. The next steps in these experiments will now be to discern the relative 
potency of cultivars and the relative contributions of SOCI and non-SOCI to these 
functional responses. In close collaboration with the traditional practitioner and 
indigenous science communities of the Pacific, we can then relate functional responses in 
these, and other cell systems, to the physiological and pathophysiological effects of kava. 
It will also be necessary to extend these studies to other cell and tissue systems. Our 
somewhat narrow focus on the mast cell will need to be extended to other cell types that 
bear the signalling machinery that confers to responsiveness to kava components, and 
which may be involved in physiological and pathophysiological effects of kava.  
A comprehensive understanding of ‘Awa chemistry is of paramount importance. 
This generates two key considerations. First, the type of extraction to be characterized 
has important implications. There is a tension between fidelity to the traditional aqueous 
extractions of primarily root samples, and the need to analyze organic extracts of aerial 
and root powders that are the major nutraceutical forms of commercialized ‘Awa.   
There is good evidence that kava toxicity and efficacy are linked to extraction 
method. Since both traditional and commercial/organic extracts are public health issues, 
both need to be examined comprehensively. Close linkages with the traditional 
practitioner community allow indigenous knowledge to inform such studies, avoiding 
situations exemplified by the 2010-12 National Toxicology Program’s comprehensive 
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examination of kava [69], which utilized only organic extraction methods that cannot 
necessarily be extrapolated to the daily ingestions that are prevalent in Pacific island 
communities. In section 2.4.2., we undertook 9 separate fractionation approaches, with 
data from just one of these fractionation and subfractionations presented here. This 
experience illustrated the challenges of a coupled fractionation-bioassay approach. Future 
experiments will instead focus upon a comprehensive ‘Awa metabolome, with an 
increased reliance on data mining approaches to provide candidate linkages between 
metabolome characteristics and effects on human physiology. 
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CHAPTER 3:  
 
3. INTRODUCTION 	
 Results from Chapter 2 suggest that a diverse secondary metabolome is 
contributing to the physiological and pathophysiological effects of kava.  One important 
factor that affects the production of metabolites is the plant’s microbiome as well as the 
surrounding soil.  In this chapter, we take the first look at the kava-associated and soil-
associated microbiome.  Soil and root samples were V4 16S sequenced to provide the 
first categorization of the kava microbiome as well as to compare and contrast the 
microbiome of the two important cultivars, Papa‘ele‘ele and Hanakapi‘ai.  Additionally, 
at the request of the ‘Awa community, we examined the effect that traditional washing 
has on the root microbiome of the cultivar Papa kea.  Currently, these finding are under 
review by the kava scientific and cultural community in a draft paper reproduced below:   
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Microbiome	analysis	of	Piper	methysticum	and	associated	soil	in	
medicinally,		ritually	and	economically	important	cultivars	
 A. Showman, M. Speck, J.D. Baker, E. Johnston, J ,Konanui, A.L. Small-
Howard and H. Turner 
 
 3.1. Abstract 
Kava is a soporific, anxiolytic and relaxant drink in widespread ritual and 
recreational use throughout the Pacific. Kava is prepared from the roots and stems of 
Piper methysticum, variously known as ‘Awa, sakau, ava, kava-kava and yaqona in 
Pacific Island cultures. Indigenous medicinal knowledge suggests that there are a wide 
variety of therapeutic uses of kava, and these extend beyond purely GABA-ergic effects 
that are associated with the anxiolytic effects of its kavalactones. Emerging evidence 
suggest that there is likely to be an extensive secondary metabolome in kava that is 
relevant to human exposure. In other natural product systems (e.g. Cannabis sativa), the 
deterministic effect of the plant and soil-associated microbiomes on secondary 
metabolome has been demonstrated. Moreover, indigenous pharmacopeia for kava 
describes nuances between cultivars and growth locations that suggest a potential 
influence of environment upon efficacy. Here, we test dual hypotheses that significant 
variance exists between the microbial ecology of  ‘Awa cultivars with different efficacies 
recognized by Pacific cultural practitioners, and that traditional preparative techniques 
impact the ‘Awa-associated microbiome, and the degree to which ‘Awa plants influence 
the soil microbiome in their rhizosphere. We present the first microbial ecology study of 
this plant, and set the stage for future studies of the links between microbiome and 
secondary metabolome. 
 3.2 Introduction 
Drinks prepared either ritually, or recreationally, from the ground rhizome and 
root of Piper methysticum play a key role in Pacific island cultures [52-56]. The 
beverages ‘Awa, sakau, ava, kava-kava and yaqona (Hawai‘i, Micronesia, Tonga and the 
Marquesas Islands, Fiji) play a role in traditional consensus building, ceremonial 
community events and ethnomedicine, [54, 57, 58]. Recent commercialization and 
nutraceutical development have also extended kava’s use to a global audience. The 
globalization of kava juxtaposes Western drug discovery approaches with Traditional 
Pharmacological Knowledge (TPK) [1, 15, 19, 59, 86].  Kava (as beverage made from 
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brewed root or other plant parts) is indicated in traditional Pacific medicine for urogenital 
conditions (gonorrhoea infections, chronic cystitis, difficulty urinating), reproductive and 
women’s health (for menstrual problems and dysmenorrhea, to facilitate delivery, to 
stimulate milk production, its leaves as an abortifacient and contraceptive), 
gastrointestinal distress, respiratory ailments (asthma, coughs, and tuberculosis), skin 
diseases and topical wounds, and as an analgesic. Significant subtlety and nuance in TPK 
attends the precise strain, plant component and preparative method to be used [54, 55, 57-
59].  
As the ethnomedical understanding of kava begins to cross cultural boundaries, a 
rich vein of traditional wisdom that relates certain cultivars and specific growth 
locations/environmental conditions to specific indications and therapeutic efficacy is 
being exposed.  This creates an opportunity for a network pharmacology approach, where 
the nuanced genetic and environmental influences on secondary metabolome can be 
elucidated and related to efficacy using modern systems biology approaches.  There is 
also a long-term opportunity to reconcile the cultural understanding of the relationship 
between nuanced differences in the source material and efficacy between different 
growing locations, cultivars and agricultural practices, with a detailed understanding of 
the resultant change in secondary metabolite profile. We are approaching this process 
with parallel efforts in assembling a secondary metabolome and an accompanying 
microbial ecology profile (microbiome) for ‘Awa plants.  It is the latter that we report in 
this study. 
The production of secondary metabolites is highly energy intensive and relies on a 
plethora of enzyme-catalyzed synthetic pathways that are not yet fully defined. These 
synthetic pathways are sensitive to changes in the physical and biological environment of 
the whole plant. Physical influencers of secondary metabolome include light (wavelength 
and intensity), water, salt, temperature, CO2 and nutrient availability. These abiotic 
factors can dramatically influence secondary metabolite production over short timeframes. 
In addition, biotic factors, genetic, epigenetic and the plant’s associated microbial 
communities, also profoundly influence the secondary metabolome. As an example, a 
study in C. sativa showed that microbiome influences THC and other key metabolite 
levels, and this study is reinforced by others in the literature [87-89]. 
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Plants bear a complex leaf and stem microbiome, and specialized compartments 
such as flowers and nodes may exhibit even more specific microbial associations. All 
land plants associate with a soil microbiome, with a bidirectional influence of the host 
plant upon is micro-biosphere, and the soil microbiome upon plant physiology and 
responses. Root physiology and metabolism affects the microbiome in soil through 
influence on soil acidity (via root metabolism and oxidative phosphorylation) and O2 
levels. Plants also produce messenger molecules that influence microbial health and 
diversity (community structure) such as anti-microbial (defense) peptides and molecules 
that affect quorum sensing by the microbial population. Root-derived carbon, both from 
decomposition and secreted chemical that contain energy-rich carbon-carbon bonds, 
provides vital energy that again drives complexity and extent of the associated microbial 
population. Conversely, the microbiome is a major determinant of plant health and 
success. As mutualists, these microbes provide nutrients, provide resistivity towards 
environmental stressors (such as soil acidification, chemical stressors, water limitations) 
and they synthesize hormones and messengers that regulate growth and productivity. 
In the current study, we take the first step towards assessment of microbial 
influence on secondary metabolism in ‘Awa by defining the soil and plant microbiomes 
associated with two strains of Hawai‘ian ‘Awa. The microbial ecology of these plants has 
not previously been studied, and our data present the structure of three communities 
(plant, washed plant, and plant-associated soil) across two culturally significant cultivars 
of Piper methysicum, Hanakapi‘ai and Papa ‘ele ‘ele. The influence of washing 
techniques in widespread use by cultural and recreational kava users upon microbial 
community structure is also examined in the Papa kea cultivar. The data suggest 
significant differences between cultivars (Hanakapi‘ai and Papa ‘ele ‘ele samples) as 
well as significant differences in the make-up of the microbiome between washed and 
unwashed samples of Papa kea.  
 3.3. Materials and Methods 
3.3.1 Sample collection: 
Samples of ‘Awa cultivars Hanakapi‘ai, Papa ‘ele ‘ele and Papa kea were generously 
supplied by the Association for Hawai‘ian ‘Awa, Hilo, Hawai‘i. Each three-year-old 
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plant sample was harvested at Pepe‘ekeo, HI 96783, (approx. GPS coordinates: N 
19.831551 W -155.106159) in July 2013, having been cultivated in Hawai‘ian well-
drained, dark-brown/reddish-brown silty clay loams (Kaiwiki series, Soil Survey of 
Island of Hawai‘i, State of Hawai‘i, Dec 1973).  Voucher specimens of Piper 
methysticum are held by the Bishop Museum, Honolulu, Hawai‘i. Annotated specimens 
and germplasm of the Hawai‘ian cultivars traditionally named here are documented in the 
archives of the Association of Hawai‘ian ‘Awa, Hilo, Hawai‘i [1]. The cultivar library of 
the Association for Hawai‘ian ‘Awa contains freely available specimens of the cultivars 
used here.  Samples analyzed for the comparative cultivar microbiome were soil with 
roots of Papa ‘ele ‘ele and Hanakapi‘ai in addition to bulk soil samples collected 
approximately one meter from the root base of the plants.  Samples for the comparison of 
traditional washed roots vs. unwashed roots consisted of Papa kea roots with loose soil 
brushed away (unwashed) and Papa kea roots washed with tap water through a high 
power washer that results in removal of some of the epidermis and rhizosphere. 
3.3.2. Sample Analysis Methods: 
Root and soil samples were processed (Second Genome, South San Francisco, CA). 
Samples were processed in a Good Laboratory Practices (GLP) compliant laboratory 
running Quality Management Systems and Standard Operating Procedures (Second 
Genome, South San Francisco, CA) for sample and data tracking. QC and QA metrics are 
maintained for all sample handling, processing and storage procedures. Microbial DNA 
was extracted using MoBio PowerPlant and PowerSoil DNA Isolation kits respectively 
(MO BIO Laboratories, Inc., Carlsbad, CA). Five extractions were performed on each 
sample. The extracted DNA concentration ranged between 16.8 to 37.9 ng/µL. All 
samples were quantified via the Qubit® Quant-iT dsDNA Broad-Range Kit (Invitrogen, 
Life Technologies, Grand Island, NY) to ensure that they met minimum concentration 
and mass of DNA.  
To enrich the sample for bacterial 16S V4 rDNA region, DNA was amplified utilizing 
fusion primers designed against the surrounding conserved regions, which are tailed with 
sequences to incorporate Illumina (San Diego, CA) flow cell adapters and indexing 
barcodes. Each sample was PCR amplified with two differently bar coded V4 fusion 
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primers. 30 samples met the post-PCR quantification minimum and were advanced for 
pooling and sequencing. For each sample, amplified products were concentrated using a 
solid-phase reversible immobilization method for the purification of PCR products and 
quantified by electrophoresis using an Agilent 2100 Bioanalyzer®. The pooled samples 
containing 30 16S rRNA gene V4-region amplified and barcoded samples were loaded 
into the MiSeq® reagent cartridge, and then onto the instrument along with the flow cell. 
After cluster formation on the MiSeq instrument, the amplicons were sequenced for 250 
cycles with custom primers designed for paired-end sequencing. 
3.3.3. Data Analysis Methods: 
(a) Sequence Processing. Using QIIME [90] and custom scripts, sequences were quality 
filtered and demultiplexed using exact matches to the supplied DNA barcodes. Resulting 
sequences were then searched against the Greengenes [91] reference database of 16S 
sequences, clustered at 97% by uclust (closed-reference OTU picking). The longest 
sequence from each Operation Taxonomic Unit (OTU) thus formed was then used as the 
OTU representative sequence and assigned taxonomic classification via mothur's 
bayesian classifier, trained against the Greengenes database clustered at 98%. (b) OTU 
(Operational Taxonomic Unit) Filters. Taxa are filtered to those present in at least one of 
the samples (Filter-1) or to taxa significantly increased in their abundance in one category 
compared to the alternate categories (Filter-5). For Filter-5, ANOVA (analysis of 
variance) was employed to calculate p-values. Additionally, q-values were calculated 
using the Benjamini-Hochberg procedure to correct p-values, controlling for false 
discovery rates. (c) Summarization. We consider the abundance of each OTU. In some 
situations we explicitly consider only the incidence (the presence or absence) of each 
OTU. (d) Sampling normalization. We employed two approaches to account for uneven 
sequencing depth. In chapter section 3.4.2., we selected 209,085 sequences from each 
sample before calculating community-wide dissimilarity measures. This removes the bias 
due to sequencing depth that would otherwise affect Principal Coordinate Analysis 
(PCoA) plots and Adonis tests, among other analyses. In section 3.4.3. of this chapter and 
beyond, samples were normalized to 1 billion counts, thus the relative abundance of each 
OTU in this report (beginning with section 3.4.3.) represents the relative abundance in a 
sample per billion sequences in that sample. (e) Sample to sample distance functions. All 
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profiles are inter-compared in a pair-wise fashion to determine a dissimilarity score and 
store it in a distance/ dissimilarity matrix. The distance functions are chosen to allow 
similar biological samples to produce only small dissimilarity scores. The Weighted 
UniFrac [92] dissimilarity utilizes the taxon abundance differences across samples but 
employs a pair-wise normalization by dividing the sum of differences by the sum of all 
abundances. We also employ the related UniFrac measure, which considers only the 
presence or absence of taxa. (f) Diversity, ordination, clustering, and classification 
methods. Alpha Diversity Measurements used include non-parametric asymptotic 
estimators species-based measures, the Chao 1 Index (the number of rare OTUs found in 
a sample using singletons and doubletons) and ACE (Abundance-based Coverage 
Estimator), which compare the frequency of rare species in a sample [93]. Non-
parametric quantitative species-based measurements used were the Shannon Index, which 
quantifies the uncertainty in the species identity of a randomly chosen individual in the 
sample looking at the number of individuals and the number of taxa; the Simpson Index 
measuring ‘even-ness’ of a community (strength of dominance with weight towards the 
abundance of the most common species and varying inversely with species diversity) [94] 
with variance from 0-1; where, zero represents no diversity and 1, for maximum diversity 
[95]; Inverse-Simpson Index equivalent to one over the probability that two randomly 
chosen individuals will be the same species with values starting at one and the higher the 
value, the greater the diversity; and Fisher Index, similar to the inverse-Simpson, but 
assumes that species abundance follows a log distribution with increase in sample size 
resulting in the collection of rare species [96].  (g) Two-dimensional ordinations and 
hierarchical clustering maps Samples in the form of dendrograms were created to 
graphically summarize the inter-sample relationships. To create dendrograms, the 
samples from the distance matrix are clustered hierarchically using the average-neighbor 
(HC-AN) method. Principal Coordinate Analysis (PCoA), a method of two-dimensional 
ordination plotting that is used to visualize complex relationships between samples, was 
performed by Second Genome.  PCoA uses the dissimilarity values to position the points 
relative to each other.  Additional two-dimensional plotting via Detrended 
Correspondence Analysis (DCA) was conducted in RStudio [97-99].  DCA ordination 
shifts samples cores along each axis allowing an average width tolerance equal to one and 
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equalizes species tolerances without changing sample order; minimum sample score is 
zero for both axes and are units of beta-diversity (units of species standard deviation) 
[100]. (h) Whole microbiome significance testing. The Adonis test is utilized for finding 
significant whole microbiome differences among discrete categorical or continuous 
variables. In this randomization/Monte Carlo permutation test, the samples are randomly 
reassigned to the various sample categories, and the mean normalized cross-category 
differences from each permutation are compared to the true cross-category differences. 
The fraction of permutations with greater distinction among categories (larger cross-
category differences) than that observed with the non-permuted data reported as the p-
value for the Adonis test. 
3.3.4. Data visualization: 
Heatmaps: The heatmaps were generated using the phyloseq package for the R statistical 
software [98], which incorporates parts of the NeatMap package for R [101]. Methods 
suited for calculating ecological distances and ordination positions were chosen for 
calculating cell values. These include the Detrended Correspondence Analysis (DCA) 
ordination and the weighted UniFrac distance methods, which follow the same 
methodology used for our ordination plots. DCA considers the underlying species 
distribution and may more closely follow the species gradient amongst samples. The 
weighted UniFrac takes into account relative species abundance as well as phylogenetic 
distances while calculating the distance matrix.  
Circular Trees: Circular trees were used to display the phylogenetic relationships among 
differentially abundant OTUs. A Welch test is performed across the two groups of 
samples using the abundance metrics. Those OTUs significantly below the chosen p-
value threshold were then grouped into families, and the one OTU with the greatest 
difference between the two group means from each family is selected for inclusion in the 
circular tree. When a family contains OTUs that are significantly increased in the second 
group relative to the first, and also OTUs that are significantly decreased, one OTU 
exhibiting each pattern is selected. A representative 16S rRNA gene from each of the 
resulting OTUs is then aligned and used to infer a phylogenetic tree. The tree, taxonomy 
labels and abundance data are rendered in iTOL [102]. The rings around the tree 
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comprise a heatmap, and the order of samples from innermost to outermost represents 
unwashed and washed roots, respectively.  Heatmap Z-scores are represent by teal to red 
with red indicating the OTU was more abundant in that sample than in the mean of the 
baseline samples, and teal indicates the OTU was less abundant.  The color saturation 
indicates the degree of difference from the mean value of the baseline samples. 
3.3.5. Statistical Analysis:  
Sequence processing, summarization, normalization, sample-to-sample distance metrics, 
ordination/clustering and significance testing were conducted using Second Genome’s 
PhyCA-StatsTM (South San Francisco, CA) analysis software package was used for 
multivariate statistical analysis. 
 3.4 Results 
3.4.1. Archaea and bacteria taxon richness at the phylum level between kava 
cultivars with and without pre-ingestion washing protocols.  
The samples that we chose to compare were in two broad categories: (a) 
comparison between cultivars, (b) between soil closely associated with the root ball and a 
more distant bulk soil sample used as a control, and (c) within a cultivar which had been 
treated, or not, with a specific washing protocol in use by the indigenous community and 
proposed by them to be associated with improved quality of the resulting drink. Five 
replicates from each sample were obtained for microbiome sequencing and included 
Sample 1: Hanakapi‘ai roots with soil (HS), Sample 2: Hanakapi‘ai bulk control soil 
(HC) obtained approximately 1 meter from root ball, Sample 3: Papa ‘ele ‘ele root 
samples containing soil (PS), Sample 4: Papa ‘ele ‘ele bulk control soil (PC) obtained 
approximately 1 meter from root ball, Sample 5: Papa kea ground root/stump washed 
(RC), and Sample 6: Papa kea ground root/stump unwashed (RD). See Figure 7. for a 
schematic of the sampling scheme and Table 3 for a list of samples, cultivar and type or 
treatment where applicable.  .  
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Figure 7. Cultivar Location and Sampling Schematic. 
A. Samples of ‘Awa cultivars Hanakapi‘ai, Papa ‘ele ‘ele and Papa kea were generously 
supplied by the Association for Hawai‘ian ‘Awa, Hilo, Hawai‘i. Pepe‘ekeo, HI 96783  
(approx. GPS coordinates: N 19.831551 W -155.106159). B. We obtained samples of 
Papa ‘ele ‘ele and Hanakapi‘ai roots with soil and bulk soil control collected 
approximately one meter from the root base of the plants.  Traditional washed roots vs. 
unwashed roots consisted of Papa kea roots with loose soil brushed away (unwashed) 
and Papa kea roots washed with tap water through a high power washer.  
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Table 3. Sample identification, cultivar and type.  
List of sample IDs by cultivar and sample type or treatment as applicable (Associated 
with Figure 7.B.). 
 
Sequence coverage was variable across the sample replicates ranging from a 
minimum of 209,085 (RC.5) sequences to a maximum of 1,243,456 (RD.1); RD.1 most 
likely is a result of PCR over amplification. Most sequences were classifiable to the 
genus level using Bayesian classifier approach at 80% confidence. P-values were 
adjusted to correct for false discovery rate, and 209,085 sequences from each sample 
were randomly selected before calculating phylum richness as an integer.  Figure 8. 
shows that bacterial phylum richness ranged in integers from 10 to 40, whereas archaeal 
phylum richness ranged from integers 0 to 1.  A significant difference in bacterial 
richness at the phylum level was observed (p < 0.05) in the Papa kea root samples 
(RC/RD) compared to Papa ‘ele ‘ele (PC/PS) and Hanakapi‘ai (HC/HS) samples by 
using ANOVA coupled with a Tukey HSD (honest significant difference) test.   
Cultivar  Sample IDs Sample Type 
Papa kea 
RC.1, RC.2, RC.3, RC.4, RC.5 Washed roots 
RD.1, RD.2, RD.3, RD.4, RD.5 Unwashed roots 
Hanakapi‘ai 
HS.1, HS.2, HS.3, HS.4, HS.5 Roots w/ soil 
HC.1, HC.2, HC.3, HC.4, HC.5 Bulk Control  Soil 
Papa ‘ele ‘ele 
PS.1, PS.2, PS.3, PS.4, PS.5 Roots w/ soil 
PC.1, PC.2, PC.3, PC.4, PC.5 Bulk Control  Soil 
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Figure 8. Archaea and bacteria taxon richness at the phylum level. 
We randomly selected 209,085 sequences from each sample before calculating phylum 
richness. These data are displayed as Achaea (light green) and Bacterial Phylum Richness 
(teal). Abbreviation Identifiers are listed in Bacterial phylum richness ranged from 10 to 
40, whereas archaeal phylum richness ranged from 0 to 1.  A significant difference in 
bacterial richness at the phylum level was observed (p < 0.05) in the Papa kea root 
samples for both washed and unwashed compared to Papa ‘ele ‘ele and Hanakapi‘ai soil 
with root and bulk soil samples by using ANOVA coupled with a Tukey HSD. 
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Figure 9. Phylum Composition shows the dominance of Proteobacteria (54.6% 
on average) was observed for all of the samples. Washed and unwashed root samples 
exhibit higher abundances of Proteobacteria (80.3% on average) compared to PC/PS and 
HC/HS samples (41.7% on average). The top 9 phyla represent on average 96.8% of each 
rarefied samples’ sequences. For all top 9 phyla, significant differences (those with a p-
value less than 0.05) in their relative proportions were detected in the RC/RD roots 
compared to PC/PS and HC/HS sample categories by using ANOVA coupled with a 
Tukey HSD. Interestingly, of the other nine phylum represented, unwashed samples 
showed a higher percentage of Firmicutes than PC/PS and HC/HS samples while washed 
samples seemed to maintain similar percentages as to these samples.  Furthermore, 
Gemmatimonadetes were nearly undetectable in most washed and unwashed root samples 
of Papa kea.   
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Figure 9. Phylum level composition 
OTUs not classified at the phylum level were omitted from this analysis and Figure We 
randomly selected 209,085 sequences from each sample before calculating proportions of 
OTUs.  These data are displayed as percent of 100 with the top nine phyla representing 
on average 96.% of each rarefied sample’s sequence. Abbreviations are RC.1-5: washed 
Papa kea roots, RD.1-5: unwashed Papa kea roots, HS.1-5: Hanakapi‘ai soil with roots, 
HC.1-5: Hanakapi‘ai bulk soil, PS.1-5: Papa ‘ele ‘ele soil with roots and PC.1-5: Papa 
‘ele ‘ele bulk soil.   For all top 9 phyla, significant differences (p < 0.05) in their relative 
proportions were detected in the kava root sample group (washed and unwashed) 
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compared to Papa ‘ele ‘ele and Hanakapi‘ai sample categories by using ANOVA 
coupled with a Tukey HSD. 	
Figure 10. shows Phylum level relative abundance across the kava root and soil 
samples.  Random selection of 209,085 sequences shows a dominance of Proteobacteria 
with an average of 67.7% for all samples with washed and unwashed roots exhibiting 
even higher abundances of Proteobacteria with an average of 98.2% compared to PC/PS 
and HC/HS (average of 42.5%).  The top 9 phyla represent an average of 98.2% of each 
of the sequences of the rarefied samples. In all top 9 phyla significant differences (p < 
0.05) in relative abundance were detected in the washed and unwashed root samples 
compared to the PC/PS and HC/HS samples by using ANOVA coupled with a Tukey 
HSD.   
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Figure 10. Comparison of phylum-level proportional abundance across samples. 
The bar chart displays the 9 phyla with the largest relative abundance found by summing 
the sequence abundance from the OTUs within the phylum.  We randomly selected 
209,085 sequences from each sample before calculating phylum abundance. The top 9 
phyla represent on average 98.2% of each rarefied samples’ sequences. Abbreviations are 
RC.1-5: washed Papa kea roots, RD.1-5: unwashed Papa kea roots, HS.1-5: Hanakapi‘ai 
soil with roots, HC.1-5: Hanakapi‘ai bulk soil, PS.1-5: Papa ‘ele ‘ele soil with roots and 
PC.1-5: Papa ‘ele ‘ele bulk soil.  In all top 9 phyla significant differences (p < 0.05) in 
relative abundance were detected in the Papa kea root samples group (washed and 
unwashed) compared to Papa ‘ele ‘ele and Hanakapi‘ai sample categories by using 
ANOVA coupled with a Tukey HSD. 
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3.4.2. Whole Microbiome Analysis 	
Alpha and Beta diversity analysis (Filter 1: abundance of 13,333 taxa present in at 
least one sample) was considered with comparisons between between Hanakapi‘ai 
HC/HS and Papa ‘ele ‘ele PC/PS samples compared to Papa kea washed and unwashed 
roots as well as individual comparisons of these treatments.  Figure 11. shows that both 
qualitative and quantitative indices of alpha diversity generally indicate significant 
separation between Hanakapi‘ai HC/HS and Papa ‘ele ‘ele PC/PS samples compared to 
Papa kea washed and unwashed roots.  Simpson Index results showed moderate 
separation between washed and unwashed roots compared to the HC/HS and PC/PS; 
Inverse Simpson showed relatively significant separation of most HC/HS and PC/PS 
samples with only moderate separation of samples HC.2 and HS.2 versus Papa kea 
washed and unwashed roots.   
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Figure 11. Ordination by sample treatment weighted. 
We considered alpha diversity expressed as species richness considering data from the 
whole microbiome (Filter 1: 13,333 taxa present in at least one of the samples). Non-
parametric, qualitative indices used: Chao1 and ACE; Non-parametric, quantitative 
indices used: Shannon, Simpson, Inverse Simpson and Fisher. Horizontal axes from left 
to right are in order of Sample key from top to bottom for each indices.  Abbreviations 
are RC.1-5: washed Papa kea roots, RD.1-5: unwashed Papa kea roots, HS.1-5: 
Hanakapi‘ai soil with roots, HC.1-5: Hanakapi‘ai bulk soil, PS.1-5: Papa ‘ele ‘ele soil 
with roots and PC.1-5: Papa ‘ele ‘ele bulk soil. 
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Table 4. Microbiome differences by categories.  
A significant microbiome difference was observed in samples grouped by the categories 
Wash, Roots, Roots4way, Hanakapi‘ai, Papa ‘ele ‘ele, Mass, Wash_Roots and PCRyield 
based on Weighted UniFrac metric and UniFrac metric on the presence/absence of 
13,333 taxa. The detected microbial community relationship showed no significant 
dependences on gDNAlabCon and nSeq16S based on Weighted UniFrac metric and 
UniFrac metric on the presence/absence of 13,333 taxa. 
 
The analysis of the impact of washing techniques employed during kava 
preparation was an important interest of the collaborating traditional practitioners, so 
additional Detrended Correspondence Analysis (DCA) of washed and unwashed samples 
was conducted, (Figure 12.).  This indicated a variance of 89.9% (Axis 1: 77.3% and 
Axis 2: 12.6%), which suggests that unwashed and washed samples share few species 
with each other. Weighted and Unweighted UniFrac also showed a moderate separation 
of washed and unwashed roots with the Adonis test (metric based on 13,333 taxa present 
in at least one sample) yielding a p-value of 0.044 and 0.012, respectively as indicated in 
Table 5.   
Principal Coordinate Analysis PCoA of PC/PS versus HC/HS samples 
(roots4way) for both Weighted and Unweighted UniFrac demonstrated a 4% and 6% 
Category Bins Sample Count WUnifrac UniFrac 
HC-AN Distinct Differentiating OTU Count 
at1	 bt1	 at5	 at5	
Wash uw | w 5 | 5 0.044 0.012 No No NA 256 
Roots abs | pres 10 | 10 0.017 0.032 No No NA NA 
Roots4way HC | HS | PC | PS 5 | 5 | 5 | 5 0.001 0.001 No Yes NA NA 
Hanakapi‘ ai HC | HS 5 | 5 0.009 0.008 NA Yes NA 1895 
Papa ‘ ele ‘ ele PC | PS 5 | 5 0.013 0.004 Yes Yes NA 2796 
Wash_Roots abs | pres | uw | w 10 | 10 | 5 | 5 0.001 0.001 NA NA NA NA 
gDNAlabCon continuous 30 0.265 0.209 NA NA NA NA 
Mass continuous 30 0.001 0.001 NA NA NA NA 
PCRyield continuous 30 0.002 0.002 NA NA NA NA 
nSeq16S continuous 30 0.409 0.346 NA NA NA NA 
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variation, respectively (data not shown).  Weighted PCoA results comparing HC and PC 
bulk soil samples did yield an Adonis test p-value of 0.017 suggesting significant 
microbiome difference observed for at least one sample; moreover, a separation of 
microbiome between HC/HS and PC/PS (roots4way) Adonis test yielded a p-value of 
0.001 along axis 2 (Table 5) indicating a significant microbiome difference was observed 
for at least one sample category.  Weighted PCoA analysis did not reveal separation 
between bulk soil samples HC and PC versus roots samples HS and PS; however the 
Adonis test yielded a p-value of 0.032 indicating significant microbiome difference for at 
least one sample category.  Further Detrended Correspondence Analysis (DCA) of 
Hanakapi‘ai samples and Papa samples showed significant variance between HC and PC 
samples versus HS and PS samples. Figure 13. indicated a 70.9% variance between HC 
verses HS (Axis 1: 42.6% and Axis 2: 28.3%).  Similarly, DCA analysis of Papa ‘ele ‘ele 
samples (Figure 14.) demonstrated an 86.1% variance between PC verses PS (Axis 1 
72.1% and Axis 2: 14%).  Both PCoA and DCA indicate significant differences in the 
microbiome of bulk soil samples and roots. Figure 15. shows Hierarchical Clustering 
based on Weighted UniFrac distance between samples revealed separate clusters of PC 
and PS samples of the factors roots4way and Papa while no clustering was noted for the 
other factors.   
In summary, significant microbiome differences were observed in samples 
grouped by the categories Wash, Roots, Roots4way, Hanakapi‘ai, Papa ‘ele ‘ele, Mass, 
Wash_Roots and PCR yield based on Weighted UniFrac metric and presence/absence 
UniFrac metric of 13,333 taxa (Table 5).  
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Figure 12. DCA of treatment washed vs. unwashed Papa kea.  
Detrended Correspondence Analysis (DCA) based on weighted UniFrac distance 
between 1616 taxa present in at least one sample. Axes are scaled in SD units with 
unwashed samples on the left sharing few species with washed samples on the right. 
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Figure 13. DCA of Hanakapi‘ai soil with roots vs. bulk soil.  
Detrended Correspondence Analysis (DCA) based on weighted UniFrac distance 
between 13,333 taxa present in at least one sample. Axes are scaled in SD units with bulk 
control soil samples on the left sharing few species with root with soil samples on the 
right.  DCA analysis explains 70.9% of variance between Hanakapi‘ai bulk soil and 
Hanakapi‘ai soil with roots  (Axis 1: 42.6% of variance; Axis 2: 28.3% of variance. 
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Figure 14. DCA of Papa ‘ele ‘ele soil with roots vs. bulk soil.  
Detrended Correspondence Analysis (DCA) based on weighted UniFrac distance 
between 13,333 taxa present in at least one sample. Axes are scaled in SD units with bulk 
control soil samples on the left sharing few species with root with soil samples on the 
right.  DCA analysis explains 86.1% of variance between Papa ‘ele ‘ele bulk soil and 
Papa ‘ele ‘ele  soil with roots  (Axis 1: 72.1% of variance; Axis 2: 14% of variance.   
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Figure 15. Hierarchical clustering weighted (average linkage). 
Based on Weighted UniFrac distance between samples given abundance of 13,333 taxa 
present in at least one sample.  HC-AN analysis based on the abundance of 13,333 taxa 
revealed separate clusters comprised of PC and PS samples of the factors Roots4way and 
Papa ‘ele ‘ele. No clusters of samples in the factors Wash, Roots and Hanakapi‘ai were 
observed.  		
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3.4.3.Washing separates OTUs 
We assessed the Operational Taxonomic Unit (OTU) diversity in washed and 
unwashed Papa kea samples. Alpha and Beta diversity analysis, based on weighted 
UniFrac distance between 256 taxa present in at least one sample (Filter 5: taxa with 
significant abundance differences in one category compared to alternate categories using 
ANOVA) was considered with comparisons between RC (washed) and RD (unwashed) 
Papa kea root samples. Figure 16. demonstrates that both qualitative and quantitative 
indices of alpha diversity generally indicate moderate separation between washed and 
unwashed Papa kea samples.  Specifically, Simpson and Inverse Simpson Indices 
showed moderate separation between RC and RD samples with replicates RC.3 and RD.2 
only slightly separated; however RD.2 showed relatively high OTU diversity and largest 
sequence coverage (~700,000) behind sample RD.1 (1,243,456).  This variance in OTUs 
for these two replicates may help to explain their general separation from the other 
unwashed replicates. Detrended Correspondence Analysis (DCA) of washed and 
unwashed samples as (Figure 17.) explains a variance of 84.8% (Axis 1: 75.8% and Axis 
2: 9%), demonstrating differences in OTU selection due to root treatment.  ANOVA 
Hierarchical Clustering based on Weighted UniFrac of 256 taxa (Figure 18.) revealed 
separate clustering of RC and RD samples based on treatment.   
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Figure 16. Ordination of Papa kea washed vs. unwashed. 
We considered alpha diversity expressed as taxa with significant abundance (Filter 5: 
abundance of 256 taxa with significant abundance differences across at least one of the 
categories). Non-parametric, qualitative indices used: Chao1 and ACE; Non-parametric, 
quantitative indices used: Shannon, Simpson, Inverse Simpson and Fisher. Horizontal 
axes from left to right are RC.1, RC.2, RC.3, RC.4, RC.5, RD.1, RD.2, RD.3, RD.4, and 
RD.5 for each indices.  Abbreviations are RC.1-5: washed Papa kea roots and RD.1-5: 
unwashed Papa kea roots.	
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Figure 17. DCA of Papa kea washed vs. unwashed.  
Detrended Correspondence Analysis (DCA) based on weighted UniFrac distance based 
on Weighted UniFrac distance between samples given abundance of 256 taxa with 
significant abundance differences across at least one of the categories. 
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Figure 18. ANOVA hierarchical clustering weighted. 
Based on Weighted UniFrac distance between samples given abundance of 256 taxa with 
significant abundance differences across at least one of the categories. 
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We investigated profiles of OTUs (Filter 5) of washed and unwashed samples 
Papa kea root/associated soil samples based on the lowest p-values.  Of particular interest 
in these analyses are any gains in OTU diversity associated with washing as these may 
reflect (1) post-washing opportunistic colonization, (2) contamination form human 
contact during the washing process, and (3) may provide a framework for understanding 
practitioner assertions as to the benefits of washing. Figure 19. (with identifications of 
OTUs on Table 5) showed that all selected OTUs belonged to one of the top 2 phyla: 
Proteobacteria (11), Firmicutes (1).  We asked of the 12 selected OTUs, seven showed 
significant increases in unwashed samples compared to washed samples including OTU 
336164 (Class: Bacilli), which contains several known pathogenic species, which include 
Bacillus anthracis Cohn, Bacillus cereus Frankland and Frankland, and to a lesser extent 
Bacillus subtilis Cohn, Bacillus licheniformis Chester are all capable of causing intestinal 
infections usually from handling infected material or ingesting infected meat [103].  Four 
taxa (950606, 53498, 9939, 62346) identified to family Enterobacteriaceae, demonstrated 
greater selection in washed samples versus unwashed samples; many species in this 
family are probiotic and may support assertions of gastro-intestinal benefits from 
practitioners.  Additionally, taxa 121180, genus Erwinia was also selected for in washed 
samples with this genus being linked to several plant pathogenic species responsible for 
blight on Rosaceae crops.  It is not surprising that this genus would be found among the 
roots of ‘Awa as blight has been a problem for some growers appearing on stems and as 
‘shot holes’ in leaves and can result in plant die-back [104].  
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Figure 19. OTUs profiles with lowest p-values for washed and unwashed Papa kea 
samples. 
Profiles of at5 OTUs generating the lowest p-values; p-values shown at top right of each 
OTU plot are unadjusted for multiple testing. The y-axis represents the OTU abundance. 
Samples are grouped and colored by category along the x-axis in the following order: 
RD.1, RD.2, RD.3, RD.4, RD.5, RC.1, RC.2, RC.3, RC.4 and RC.5.  OTU (as listed on 
top left of each plot) are identified in Table 5.   
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Table 5. ANOVA annotations of the OTUs with the lowest p-value.  
Taxa identification by OTUs of the top 12 phyla (associated with Figure 19).  OTUs are 
listed from the left, middle and right, then top to bottom as depicted in Figure No OTUs 
were identified to species. 
 
Six families contained OTUs of either higher or lower abundances between 
washed (RC) and unwashed (RD) Papa kea samples, and these were compared in a 
heatmap tree (Figure 20.). From the 13,333 OTUs present in the study, 256 OTUs (within 
25 families) were significantly different (p < 0.05) in one of the comparison groups. The 
one OTU with the greatest difference between the two group means (washed vs. 
unwashed groups) from each family was selected. Actinobacteria and Acidobacteria 
generally were less abundant in unwashed samples compared to washed samples while 
Firmicutes and Proteobacteria showed mixed results with Proteobacteria OTUs 108916, 
950606, 926370, 219439, and 1120966 and Firmicutes OTU 839282 being higher in 
abundance for washed samples.  The single OTU for Chloroflexi demonstrated higher 
abundance in washed samples; possibly reflecting extraction of these commonly plant 
associated bacteria from the root or opportunistic colonization due to the presence of 
chlorine in the wash water as many of the Chloroflexi function as anaerobic, obligate 
organohalide respirers converting compounds such as inorganic chlorine in to 
organochlorine compounds through chloroperoxidase activity [105]. 
OTU Phylum Class Order Family Genus 
L
ef
t 
950606 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae unclassified 
924547 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae unclassified 
691423 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae unclassified 
632346 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae unclassified 
M
id
dl
e 
534898 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae unclassified 
30929 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae unclassified 
760529 Proteobacteria Gammaproteobacteria unclassified unclassified unclassified 
121180 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Erwinia 
R
ig
ht
 
9939 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae unclassified 
336164 Firmicutes Bacilli unclassified unclassified unclassified 
558281 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae unclassified 
124309 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae unclassified 
Showman,	Chemical	and	Microbial	Ecology	of	‘Awa,	Piper	methysticum	(G.	Forst)	
	 73	
 
Figure 20. Heatmap tree comparing phylum of washed samples (inner rings) and 
unwashed samples (outer rings). 
From the 13,333 OTUs present in the study, 256 OTUs (within 25 families) were 
significantly different (p < 0.05) in one of the comparison groups. The one OTU with the 
greatest difference between the two group means (washed vs unwashed groups) from 
each family was selected. 6 families contained OTUs with both higher and lower 
abundance scores in the washed compared to the unwashed samples. In these 6 families, 
both OTUs were selected. An idealized tree is computed using taxonomic classifications. 
The color saturation indicates z-score, which represents the OTU differences from the 
overall mean abundance of the OTU across samples. The z-score of one OTU in one 
sample is defined as the difference between OTU abundance and mean abundance of the 
OTU across all samples, divided by the standard variation of the OTU's abundance across 
all samples. Dark blue indicates the OTU has low abundance relatively to other samples 
(z-score of -1.72); white indicates no difference from the mean; dark red indicates high 
abundance (z-score of 2.54). Of the OTUs selected, those within Actinobacteria and 
Acidobacteria generally tended to be less abundant in unwashed samples. The selected 
OTUs exhibit mixed responses in Chloroflexi, Firmicutes and Proteobacteria.  ID labels 1 
through 31 are listed and identified in Table 6. 
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Table 6. Corresponding identifiers for heatmap tree comparing phylum of washed 
and unwashed samples (Associated with Figure 20.) Label	numbers	correspond	with	inside	colored	phylum	ring	of	the	heatmap	in	Figure	20	and	are	identified	by	their	OTU	and	phylum	name.			
3.4.4. Analysis of gut-associated bacteria with washed and unwashed Papa kea 
samples.  
Figure 21. shows the relative abundance of possible human gut bacteria at the 
family level for RC and RD samples (Filter 5) for the top 150 OTUs.  The majority of the 
bacteria belong to the Family Enterobacteriaceae (54%) and Family Pseudomonadaceae 
(30%) with the remaining bacteria belonging to families Xanthomonadaceae (6%), 
Burkholderiaceae (2.7%), Alcaligenaceae (2.0%), Paenibacillaceae (2.0%), 
Enterococcaceae (1.3%), Comamonadaceae (0.7%), Lachnospiraceae (0.7%) and 
Streptococcaceae  (0.7%).  
OTUs (in order of highest to lowest average abundance) 4419276, 133961 
(Family: Pseudomonadaceae), 91962, 9994, 676211, 668514, 122049, 233220 and 
192342 (Family: Enterobacteriaceae) generally maintained similar abundance between 
washed (RC) and unwashed samples (RD).  A few OTUs demonstrated a dramatic 
decrease of gut-associated bacteria in washed samples while present in unwashed 
Label OTU Phylum Legend OTU Phylum 
01 4373459 Acidobacteria 15 573135 Proteobacteria 
02 1145388 Chloroflexi 16 622571 Proteobacteria 
03 512148 Actinobacteria 17 4301099 Proteobacteria 
04 125045 Actinobacteria 18 4308371 Proteobacteria 
05 4350881 Actinobacteria 19 108916 Proteobacteria 
06 214718 Actinobacteria 20 924547 Proteobacteria 
07 764292 Firmicutes 21 950606 Proteobacteria 
08 42642 Firmicutes 22 1118561 Proteobacteria 
09 336164 Firmicutes 23 926370 Proteobacteria 
10 4401692 Firmicutes 24 760529 Proteobacteria 
11 1100972 Firmicutes 25 635524 Proteobacteria 
12 4316928 Firmicutes 26 219439 Proteobacteria 
13 839282 Firmicutes 27 1120966 Proteobacteria 
14 781576 Firmicutes 28 7061 Proteobacteria 
29 673343 Proteobacteria 
30 4439509 Proteobacteria 
31 511916 Proteobacteria 
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samples OTUs (in order of highest to lowest difference in the mean) 394796 
(Pseudomonas viridiflava  Burkholder), 410048 (Genus: Pseudomonas), 924547 (Family: 
Enterobacteriaceae), 4416113 (Family: Enterobacteriaceae, Genus: Serratia), 802064 and 
1981302 (Family: Burkholderiaceae, Genus: Burkholderia), 691423 and 688934 (Family 
Enterobacteriaceae).  On the other hand, one OTU in the Family Enterobacteriaceae 
(539107) was dramatically higher in abundance in washed samples than unwashed 
samples suggesting selectivity by the roots for this particular bacterium.  Other OTUs 
were considerably higher in abundance for washed samples (RC) than unwashed samples 
(RD), specifically OTUs 219439 (Family: Xanthomonadaceae, Stenotrophomonas 
geniculata (Wright)), 4451011 and 544313 (Family: Pseudomonadaceae) while the 
Family Pseudomonadaceae, OTUs 4364813, 2534143 (Genus: Pseudomonas) showed a 
moderate increase in abundance. 
In summary, there is some variability in the abundance of family selectivity 
among washed and unwashed samples, but more importantly, an overall look at the 
heatmap shows traditional washing does not remove most of the bacteria keeping the root 
microbiome intact and suggesting that some of these organisms exist within the root 
interior.  
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Figure 21. Heatmap to family level comparing relative abundance of gut bacteria in 
washed and unwashed samples. 
From the 13,333 OTUs present in the study, the top 150 OTUs in families associated as 
possible gut bacteria were compared for relative abundance and selectivity between 
washed and unwashed samples.  Rainbow scale starting with magenta represents 
abundance above 30000 with red indicating absence of OTU and color hues from blue to 
orange decrease in abundance.  OTUs are labeled on the left vertically by bacteria family 
with each line representing a separate OTU: Xanthomonadaceae (A), Streptococcaceae 
(B), Pseudomonadaceae (C), Paenibacillaceae (D), Lachnospiraceae (E), 
Enterococcaceae (F), Enterobacteriaceae (G), Comamonadaceae (H), Burkholderiaceae 
(I) and Alcaligenaceae (J).  Specific OTU numbers are labeled on the right indicating 
OTUs of interest.  Samples are listed horizontally with in the following order: RC.1, 
RC.2, RC.3, RC.4, RC.5, RD.1, RD.2, RD.3, RD.4 and RD.5.	
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3.4.5. Analysis of probiotic and pathogen content of washed and unwashed Papa kea 
samples.  
Kava TPK suggests some indications that are ascribed in the modern nutraceutical 
industry to probiotic agents. We therefore asked if there was any evidence for probiotic 
microbial communities associated with Papa kea, namely families containing the genera 
Lactobacillus, Bifidobacterium and Streptococcus [106].  Out of the 150 top OTUs in 
Figure 22., probiotic families Streptococcaceae, represent by six OTUs (4468805, 
1100972, 544419, 335256, 316321, 294254, respectively), and Lactobacillaceae with two 
OTUs [781576 (Lactobacillus manihotivorans Morlon-Guyot et al.) and 291816 (Genus: 
Lactobacillus)] with such low relative abundances that they lack any distinction on the 
heatmap.  More importantly, these bacteria were present mostly in unwashed samples and 
completely eliminated on washed roots indicate that probiotic bacteria do associate with 
kava but are largely removed by the particular washing process employed by the 
practitioners involved in this study.  Figure 22. also revealed seven additional bacterial 
OTUs (labeled in red), four of which, OTUs 68617 (Family: Alcaligenanceae, Genus: 
Achromobacter), 818602, 821562, 4456889 (Family: Pseudomonadaceae, Genus: 
Pseudomonas), all of which showed a decrease in abundance in washed samples 
compared to unwashed samples and are known plant or human/animal pathogens, so 
minimally traditional washing does remove pathogenic species. 
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Figure 22. Heatmap to family level comparing abundance of possible probiotic 
bacteria in washed and unwashed samples. 
From the 13,333 OTUs present in the study, the top 150 OTUs in families associated with 
probiotic bacteria were compared for relative abundance and selectivity between washed 
and unwashed samples.  Rainbow scale starting with magenta represents abundance 
above 30000 with red indicating absence of OTU and color hues from blue to orange 
decreaseing in abundance.  OTUs are labeled vertically by bacteria family with each line 
representing a separate OTU: Streptococcaceae (B), Pseudomonadaceae (C), 
Alcaligenaceae (J) and Lactobacillaceae (K).  Samples are listed horizontally with in the 
following order: RC.1, RC.2, RC.3, RC.4, RC.5, RD.1, RD.2, RD.3, RD.4 and RD.5.	
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3.4.6. Comparison between Hanakapi‘ai root samples and bulk soil  
Of 15,617 OTUs, 1,895 displayed abundance patterns with significant differences 
between HC and HS (Filter 5: taxa with significant abundance differences in one 
category compared to alternate categories using ANOVA).  Figure 23. shows that both 
qualitative and quantitative indices of alpha diversity generally indicate significant 
separation between HC and HS with the exception of HS.2, which shows more similarity 
with HC samples along all indices and as a result, Fisher alpha diversity makes HC.3 
appear closer in diversity to soil with root samples with the remaining indices showing at 
least a moderate separation.  Samples HC.2 appears on the outside of the ordination 
clusters compared to other HC samples but remains significantly separated from all HS 
samples for all indices except Inverse Simpson, which indicates a closer correlation 
between HC.2 and HS.2.   
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Figure 23. Ordination of HC and HS comparison. 
We considered alpha diversity of samples given abundance of 1,895 taxa with significant 
abundance across at least on of the categories (Filter 5).  Non-parametric, qualitative 
indices used: Chao1 and ACE; Non-parametric, quantitative indices used: Shannon, 
Simpson, Inverse Simpson and Fisher. Horizontal axis from left to right HC.1, HC.2, 
HC.3, HC.4, HC.5, HS.1, HS.2, HS.3, HS.4, HS.5 for each indices.  Abbreviations are 
HC.1-5: Hanakapi‘ai bulk control soil ~ 1 meter from roots and HS.1-5: Hanakapi‘ai 
roots with soil. 
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Detrended Correspondence Analysis (DCA) analysis (Figure 24.) shows a total 
variance of 89.6% (Axis 1: 72.3% and 17.3%).  It was also noted that HS.2 is inconsistent 
with other samples appearing more like Hanakapi‘ai bulk control soil samples on axis 2, 
and more similar to HC.2 from the y-axis perspective.  HC.5 also shows some 
dissimilarity on the y-axis compared to the main cluster; however, ordination plots across 
all indices indicated similarity of this sample to the remaining cluster.  This result is 
consistent with the results seen in Figure 23.; however, it does show notable difference in 
variation to bulk soil samples not easily depicted in the alpha diversity plots.  
Hierarchical Clustering (Figure 25.) revealed distinct clustering of HC and HS samples. 
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Figure 24. HS vs HC DCA based on weighted UniFrac. 
Detrended Correspondence Analysis (DCA) based on weighted UniFrac distance based 
on Weighted UniFrac distance between samples given abundance of 1,895 taxa with 
significant abundance differences across at least one of the categories.  Abbreviations are 
HC.1-5: Hanakapi‘ai bulk control soil ~ 1 meter from roots and HS.1-5: Hanakapi‘ai 
roots with soil.	
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Figure 25. HS vs HC hierarchical clustering weighted. 
Based on Weighted UniFrac distance between samples given abundance of 1,895 taxa 
with significant abundance differences across at least one of the categories.  Using 1,895 
at5 filtered taxa, the microbiome community characterization of samples from HC and 
HS revealed distinct cluster.  Abbreviations are HC.1-5: Hanakapi‘ai bulk control soil ~ 
1 meter from roots and HS.1-5: Hanakapi‘ai roots with soil.	
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Figure 26. (with identifications of OTUs on Table 7) outlines the profiles of 
OTUs that generate the lowest p-values; OTUs in the top 12 belong to three phyla 
Proteobacteria (9), Bacteroidetes (2) and Actinobacteria (1).  There was significant 
difference between OTUs selected for by HS samples compared to bulk soil samples, but 
more importantly, abundance was significantly reduced for 5 OTUs: 548754 and 
4377315 (Proteobacteria: Moraxellaceae), 143093 (Proteobacteria: 
Gammaproteobacteria), 590507 (Proteobacteria: Alphaproteobacteria and 1095594 
(Actinobacteria: Micromonospraceae) 
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Figure 26. HS vs HC profiles of at5 OTUs generating the lowest p-values. 
P-values shown at top of each OTU plot are unadjusted for multiple testing. The y-axis 
represents the OTU abundance. Hanakapi‘ai samples are grouped and colored by 
category along the x-axis in the following order: HC.1, HC.2, HC.3, HC.4 HC.5, HS.1, 
HS.2, HS.3, HS.4 and HS.5.  All selected OTUs of the top 12 belonged to one of 3 phyla: 
Proteobacteria (9), Bacteroidetes (2) and Actinobacteria (1).  Seven of 12 selected OTUs 
displayed a significant increase in HS samples, and OTU 1095594 
(Micromonosporaceae) was significantly greater in all HC samples.		
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Table 7. HS vs HC annotations of the OTUs with the lowest p-values.  
Corresponding taxa ID number of the top 12 phyla (associated with Figure 26) identified 
to Class, Order, Family, Genus and Species where possible.  OTUs are listed from the left, 
middle and right, then top to bottom as depicted in Figure  
 
Figure 27. (a. and b.) bacteria heatmap with identification listed in Table 8 shows 
33 families in the top 150 OTUs of the 15,617 OTUs present compared for relative 
abundance and selectivity between Hanakapi‘ai bulk soil (HC) and Hanakapi‘ai roots 
(HS) with rainbow scale starts with magenta representing higher relative abundance and 
color hues from blue to red-orange decreasing in abundance.  We log2 transformed the 
data set to more closely align scaling between Hanakapi‘ai and Papa ‘ele ‘ele for 
comparison of Family groups and OTUs between these two cultivars; however, the below 
analysis was based on relative abundance values.  Of the top 150 OTUs, the Family 
Hyphomicrobiaceae had the largest percentage at 24% with the second largest Family 
Gaiellaceae (8.7%) followed by Sinobacteraceae and Xanthomondacaea (6.7% each) and 
Koribacteraceae and Solibacteriaceae (5.3% each) with the remaining bacterial families 
each making up less than 5% and some families only represented by only one or two 
OTUs.  Overall, these results indicate that there is a large diversity among both 
OTU Phylum Class Order Family Genus Species 
L
ef
t 
4425394 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas unclassified 
996761 Bacteroidetes Sphingobacteria Sphingobacteriales Sphingobacteriaceae unclassified unclassified 
548754 Proteobacteria Gammaproteobacteria Pseudomonadales Moraxellaceae 94otu37979 97otu50624 
590507 Proteobacteria Alphaproteobacteria 85otu312 91otu812 94otu1588 97otu11171 
M
id
dl
e 
544313 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas unclassified 
4377315 Proteobacteria Gammaproteobacteria Pseudomonadales Moraxellaceae unclassified unclassified 
2371693 Proteobacteria Betaproteobacteria unclassified unclassified unclassified unclassified 
4395995 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae unclassified unclassified 
R
ig
ht
 
1095594 Actinobacteria Actinobacteria Actinomycetales Micromonosporaceae 94otu8918 97otu66145 
344892 Proteobacteria Alphaproteobacteria Rhodobacterales Rhodobacteraceae unclassified unclassified 
143093 Proteobacteria Gammaproteobacteria 34P16 91otu11085 94otu21318 unclassified 
251049 Bacteroidetes Sphingobacteriia Sphingobacteriales 91otu4379 unclassified unclassified 
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Hanakapi‘ai bulk soil and Hanakapi‘ai roots, though abundance for many OTUs was 
variable across most HC and HS samples.  An overall look at the heatmap indicates that 
samples HC.2 and HS.2 are generally inconsistent with other bulk soil and root with soil 
samples, respectively with HS.2 being more significantly different than the other samples 
in that category (see discussion). As are result, some OTUs were difficult to determine 
the trend specifically: 1129425 (Solirubrobacteraceae: Solirubrobacter), 4298129 
(Rhodospirillaceae), 994823 (Patulibacteraceae), 1110792 (Koribacteraceae: Candidatus 
Koribacter), 253167 and 52053 (Hyphomicrobiaceae: Rhodoplanes), and 1624 
(Chthoniobacteraceae: DA101).  
Outside of these issues, strong relative abundances were seen in all samples (HC 
and HS) for several OTUs with some exceptions in the Families Xanthomonadaceae 
(1118758); Sinobacteraceae (252012 except HS.5 was slightly lower); 
Hyphomicrobiaceae (4431597, 4342107 and 1657331); Hyphomicrobiaceae identified to 
Genus Rhodoplanes (248032, 156044, 136162 and 101542) and Bradyrhizobiaceae: 
Genus Bradyrhizobium (4475561 and 740317).  
Of more importance is the potential ability of the Hanakapi‘ai cultivar to select 
for specific bacteria, despite lower abundances in bulk soil.  The family heatmap revealed 
that at least 17 OTUs demonstrated some level of selectivity indicated by higher 
abundances around root with soil samples.  Strong selectivity was noted in OTUs in the 
Families Xanthamonadaceae (434357, 707290, 184325 and 34580), Sphingomonadaceae 
(243129), Sphingobacteriaceae (357684), Pseudomonadaceae (845178 and 133961), and 
Comamonadaceae (4453710).  Relatively strong selectivity for one identified as 
Nitrospiraceae: Nitrospira (89259).   
Another expectation was that relatively high abundance in bulk soil populations 
would be similar in root with soil samples due to their higher presence in the surrounding 
soil..  In contrast, our results suggested that some OTUs actually declined in abundance 
around (HS samples), which we believe may be an example of de-selectivity by roots.  In 
fact, as many as 31 OTUs demonstrated this de-selectivity by higher abundances found in 
bulk soil samples (HC) compared to roots (HS). Hanakapi‘ai bulk soil (HC) samples 
showed higher relative abundance for some OTUs compared to roots samples (HS): OTU 
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81089 (Xanthomonadaceae), 13034 (Mycobacteriaceae: Mycobacteriaceae), 235789 and 
53533 (Rhodoplanes) and higher abundance in most bulk soil samples in two OTUs in 
the family Sinobacteraceae: 4373617 and 4353076 (Steroidobacter) with some variability 
in the relative abundance.  OTU 53533 trend for de-selectivity remained strong with and 
without HS.2 being higher in abundance than other HS samples.  
 
 
Table 8. HS vs. HC annotations bacteria family heatmap.  
Numerical label with corresponding Bacterial family identification (associated with 
Figure 27.).   
  
Label Bacteria Label  Bacteria 
1 Xanthomonadaceae 18 Micromonosporaceae 
2 Syntrophobacteraceae 19 Koribacteraceae 
3 Sphingomonadaceae 20 Hyphomonadaceae 
4 Sphingobacteriaceae 21 Hyphomicrobiaceae 
5 Solirubrobacetaceae 22 Haliangiaceae 
6 Solibacteraceae 23 Gaiellaceae 
7 Sinobacteraceae 24 Entotheonellaceae 
8 Rhodospirillaceae 25 Cytophagaceae 
9 Pseudonocardiaceae 26 Conexibacteraceae 
10 Pseudomonadaceae 27 Comamonadaceae 
11 Piscirickettsiaceae 28 Chthoniobacteraceae 
12 Phyllobacteriaceae 29 Chitinophagaceae 
13 Patulibacteraceae 30 Burkholderiaceae 
14 Nocardioidaceae 31 Bradyrhizobiaceae 
15 Nitrospiraceae 32 Acidobacteriaceae 
16 Nitrosomonadaceae 33 Acetobacteraceae 
17 Mycobacteriaceae 
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Figure 27. (a.) and (b.) HS vs. HC bacteria family heatmap 	 	
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3.4.7. Comparison between Papa ‘ele ‘ele roots and bulk soil 
Similar analysis of Papa ‘ele ‘ele was conducted based on 15,617 OTUs with 
2,796 displayed abundance patterns with significant differences between PC and PS 
(Filter 5: taxa with significant abundance differences in one category compared to 
alternate categories using ANOVA), which also demonstrated separation and distinct 
clustering between bulk soil and root samples.  Figure 28. shows that both qualitative and 
quantitative indices of alpha diversity with PC samples generally well grouped while PS 
samples are more spread out; however, moderate separation is noted between PS and PC 
samples for all indices with the exception of Chao1.  The Chao 1 index, which is based 
upon the number of rare OTUs found in a sample [107], shows PS.2, PS.3, PS.4, and 
PS.5 more similar to PC samples with PS.1 showing the greatest separation but with large 
error bars.  ACE shows some similarity to the results in Chao1 indices, but appears a bit 
more separated.  Both Chao and ACE are known to underestimate true richness in small 
sample sizes such as those used in this study [108].   
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Figure 28. Ordination of PC and PS comparison. 
We considered alpha diversity of samples given abundance of 2,796 taxa with significant 
abundance across at least on of the categories (Filter 5).  Non-parametric, qualitative 
indices used: Chao1 and ACE; Non-parametric, quantitative indices used: Shannon, 
Simpson, Inverse Simpson and Fisher. Horizontal axis from left to right PC.1, PC.2, PC.3, 
PC.4, PC.5, PS.1, PS.2, PS.3, PS.4, PS.5 for each indices.  Abbreviations are PC.1-5: 
washed Papa ‘ele ‘ele bulk control soil ~ 1 meter from roots and PS.1-5: Papa ‘ele ‘ele 
roots. 
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Detrended Correspondence Analysis (DCA) analysis (Figure 29.) shows a total 
variance of 86.7% (Axis 1: 70.9% and 15.8%), and more clearly shows the separation 
between PC and PS samples including PS.1 being more consistent with PS.2 and PS.5 
samples.  Hierarchical Clustering (Figure 30.) revealed distinct clustering of PC and PS 
samples.  Figure 31. (with identifications of OTUs on Table 9) outlines the profiles of 
OTUs that generate the lowest p-values; OTUs in the top 12 belong to five phyla 
Proteobacteria (8), Nitrospirae (1), Planctomycetes (1), Acidobacteria (1) and 
Bacteroidetes (1).  OTU 4335077, genus Burkholderia, was significantly greater in all PS 
samples.  OTU 56109, class Betaproteobacteria and OTU 731730, class Acidobacteria-6, 
were also greater in abundance in PS samples compared to PC samples and OTU 
4026017, family Rhodospirillaceae showed some increase in abundance in all PS samples. 
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Figure 29. PS vs. PC DCA based on weighted UniFrac. 
Detrended Correspondence Analysis (DCA) based on weighted UniFrac distance based 
on Weighted UniFrac distance between samples given abundance of 2,796 taxa with 
significant abundance differences across at least one of the categories. 	
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Figure 30. PS vs. PC hierarchical clustering weighted (average linkage). 
Based on Weighted UniFrac distance between samples given abundance of 2,796 taxa 
with significant abundance differences across at least one of the categories.  Using 2,796 
at5 filtered taxa, the microbiome community characterization of samples from PC and PS 
revealed distinct cluster.  Abbreviations are PC.1-5: washed Papa ‘ele ‘ele bulk control 
soil ~ 1 meter from roots and PS.1-5: Papa ‘ele ‘ele roots. 
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Figure 31. PS vs. PC profiles of at5 OTUs generating the lowest p-values. 
P-values shown at top of each OTU plot are unadjusted for multiple testing. The y-axis 
represents the OTU abundance. Samples are grouped and colored by category along the 
x-axis in the following order: PC.1, PC.2, PC.3, PC.4 PC.5, PS.1, PS.2, PS.3, PS.4 and 
PS.5.  All selected OTUs of the top 12 belonged to one of 5 phyla: Proteobacteria (8), 
Nitrospirae (1), Planctomycetes (1), Acidobacteria (1) and Bacteroidetes (1).  Eight of 12 
selected OTUs displayed a significant increase in PC samples, and OTU 4335077 
(Genus: Burkholderia) was significantly greater in all PS samples.	
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Table 9. PS vs. PC annotations of the OTUs with the lowest p-values.   
Corresponding taxa ID number of the top phyla (associated with Figure 31) identified to 
Class, Order, Family, Genus and Species determinations where possible. OTUs are listed 
from the left, middle and right, then top to bottom as depicted in Figure 
 
We also investigated abundance and selectivity between Papa ‘ele ‘ele bulk soil 
(PC) and Papa ‘ele ‘ele roots (PS) [Figure 32. (a.) and (b.) bacteria heatmap with 
identification listed in Table 10.], representing 34 families in the top 150 OTUs of the 
15,617 OTUs present.  Of the top 150 OTUs, the Family Hyphomicrobiaceae had the 
largest percentage at 29.3% with the second largest Family Gaiellaceae (13.3%) followed 
by Comamonadaceae (6%).  The remaining bacterial families each made up less than 5% 
with some families represented by only one or two OTUs also indicating that a large 
diversity among both Papa ‘ele ‘ele bulk soil and roots exists though abundance for most 
OTUs was relatively consistent with some variability across many PC and PS samples. 
As with Hanakapi‘ai samples, Papa ‘ele ‘ele contained OTUs with strong relative 
abundances across all samples; for example, one OTU in the Family Gaiellaceae 
(368218) and three OTUs identified as Bradyrhizobiaceae: Bradyrhizobium (4475561, 
740317 and 573135) as well as in OTUs 1657331 (Hyphomicrobiaceae: Pedomicrobium, 
OTU Phylum Class Order Family Genus Species 
L
ef
t 
4335077 Proteobacteria Betaproteobacteria Burkholderiales Burkholderiaceae Burkholderia unclassified 
4353076 Proteobacteria Gammaproteobacteria Xanthomonadales Sinobacteraceae Steroidobacter 97otu98065 
4413363 Proteobacteria Gammaproteobacteria Xanthomonadales Sinobacteraceae 94otu40427 97otu98093 
4026017 Proteobacteria Alphaproteobacteria Rhodospirillales Rhodospirillaceae unclassified unclassified 
M
id
dl
e 
56109 Proteobacteria Betaproteobacteria 85otu2071 91otu4711 94otu13351 unclassified 
1491 Nitrospirae Nitrospira Nitrospirales Nitrospiraceae Nitrospira 97otu99102 
102030 Proteobacteria Alphaproteobacteria Ellin329 91otu10045 94otu19605 unclassified 
4349496 Bacteroidetes [Saprospirae] [Saprospirales] Saprospiraceae unclassified unclassified 
R
ig
ht
 
669338 Planctomycetes Planctomycetia Pirellulales Pirellulaceae 94otu41539 97otu46585 
113477 Proteobacteria Alphaproteobacteria Rhizobiales Rhizobiaceae unclassified unclassified 
731730 Acidobacteria Acidobacteria-6 iii1-15 91otu8728 94otu9359 unclassified 
250348 Proteobacteria Alphaproteobacteria Rhodospirillales Rhodospirillaceae 94otu18807 unclassified 
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137981 (Micrococcaceae). Papa ‘ele ‘ele samples also suggested selectivity by root 
samples (PS) with at least 29 OTUs demonstrated some level of selectivity with strong 
selectivity detected in OTUs 150689 (Sphingomonadaceae: Sphingobium), 252822 
(Rhizobiaceae: Agrobacterium), 4314416 (Methylophilaceae) and three OTUs identified 
as Pseudomonadaceae: Pseudomonas (4451011, 544313 and 133961).  We also saw de-
selectivity in Papa ‘ele ‘ele root samples (PS) with strong de-selectivity in the OTUSs 
4353076 (Sinobacteraceae: Steroidobacter), 513355 (Saprospiraceae), 4298215 
(Rhodospirillaceae) and 305897 (Nocardioidaceae: Kribbella).  
 
 
Table 10. PS vs. PC annotations bacteria family heatmap.  
Numerical label with corresponding Bacterial family identification (associated with 
Figure 32.). 
 
  
Label Bacteria Label  Bacteria 
1 Xanthomonadaceae 14 Nocardioidaceae 
2 Syntrophobacteraceae 15 Nitrospiraceae 
34 Streptomycetaceae 17 Mycobacteriaceae 
3 Sphingomonadaceae 18 Micromonosporaceae 
4 Sphingobacteriaceae 38 Micrococcaceae 
5 Solirubrobacetaceae 39 Methylophilaceae 
6 Solibacteraceae 20 Hyphomonadaceae 
7 Sinobacteraceae 21 Hyphomicrobiaceae 
35 Saprospiraceae 23 Gaiellaceae 
8 Rhodospirillaceae 40 Erythrobacteraceae 
36 Rhizobiaceae 24 Entotheonellaceae 
9 Pseudonocardiaceae 25 Cytophagaceae 
10 Pseudomonadaceae 27 Comamonadaceae 
11 Piscirickettsiaceae 28 Chthoniobacteraceae 
37 Pirellulaceae 29 Chitinophagaceae 
12 Phyllobacteriaceae 31 Bradyrhizobiaceae 
13 Patulibacteraceae 41 Alcaligenaceae 
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Figure 32. (a.) and (b.) PS vs. PC bacteria family heatmap.  
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3.4.8. Differences between Hanakapi‘ai and Papa ‘ele ‘ele family relative 
abundances 
Comparison of the family heatmaps revealed distinct differences in bacterial 
abundance and composition.  Overall, Papa ‘ele ‘ele abundance values were generally 
lower (see log2 scale), but slightly more diverse than Hanakapi‘ai samples despite having 
a higher percentage of Hyphomicrobiaceae.  The Papa ‘ele ‘ele cultivar also appears to 
demonstrate less differences between bulk soil (PC) and root samples (PS) with many 
OTUs being strongly represented across all samples suggesting that this cultivar is less 
selective of bacteria species.  Compositional difference can be seen in Table 11. and 12.  
Table 11. list bacteria families that differed in the top 150 OTUs of Hanakapi‘ai and 
Papa ‘ele ‘ele cultivars, respectively.  Hanakapi‘ai contained seven different families: 
Nitrosomonadaceae, Koribacteraceae, Haliangiaceae, Conexibacteraceae, 
Burkholderiaceae, Acidobacteriaceae and Acetobacteraceae.  Papa ‘ele ‘ele contained 
eight differing families: Streptomycetaceae, Saprospiraceae, Rhizobiaceae, Pirellulaceae, 
Micrococcaceae, Methylphilaceae, Erythrobacteraceae and Alcaligenaceae.   
Even in the case of bacterial families present in both cultivars, there are some 
differences in total representation by families as well as by specific OTUs representing 
these families. For starters, by total number of OTUs, Xanthomonadaceae, 
Solibacteraceae, Chthoniobacteraceae were more heavily represented in Hanakapi‘ai 
samples than Papa ‘ele ‘ele samples with Sinobacteraceae and Micromonosporaceae 
slightly more represented; on the other hand, Papa samples were more heavily represent 
by Hyphomicrobiaceae, Gaiellaceae and Comamonadaceae with Spingomonadaceae, 
Phyllobacteriaceae and Nocardioidaceae being slightly more represented. Table 12. lists 
the different OTUs between Hanakapi‘ai and Papa ‘ele ‘ele samples in shared families; 
consequently, all of the Xanthomonadaceae OTUs in Hanakapi‘ai samples differed from 
the one OTU in Papa samples; same was true for Solibacteraceae and mostly for 
Chthoniobacteraceae, which shared only one OTU in common.  
Of those OTUs populated in both cultivars, some show differences in abundance 
or selectivity between bulk soil samples and root samples.  For example, OTU 831386 
(Syntrophobacteraceae) was much more strongly represented across all Papa ‘ele ‘ele 
Showman,	Chemical	and	Microbial	Ecology	of	‘Awa,	Piper	methysticum	(G.	Forst)	
	 100	
samples compared to Hanakapi‘ai, but more importantly it was de-selected by Papa ‘ele 
‘ele root samples (PS).  We also noted that de-selectivity of family Mycobacteraiceae was 
strongly demonstrated in all OTUs of Hanakapi‘ai root samples including the shared 
OTU 13034, which was only moderately abundant in all Papa ‘ele ‘ele samples.   
 
 
Table 11. HS/HC and PS/PC differences in bacterial family heatmaps.  
Lists the 7 differing families found in Hanakapi‘ai samples compared to 8 differing 
families found in Papa ‘ele ‘ele samples of the top 150 OTUs for each cultivar.  
Numerical label and Family identification are the same as for the original heatmaps 
annotations. 
 
 
Hanakapi‘ai # Hanakapi‘ai Bacteria Papa ‘ele ‘ele # Papa ‘ele ‘ele Bacteria 
16 Nitrosomonadaceae 34 Streptomycetaceae 
19 Koribacteraceae 35 Saprospiraceae 
22 Haliangiaceae 36 Rhizobiaceae 
26 Conexibacteraceae 37 Pirellulaceae 
30 Burkholderiaceae 38 Micrococcaceae 
32 Acidobacteriaceae 39 Methylophilaceae 
33 Acetobacteraceae 40 Erythrobacteraceae 
  41 Alcaligenaceae 
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Table 12. HS/HC and PS/PC differences in OTUs representing the same bacterial 
family. 
List of commonly occurring bacterial families on heatmaps in the top 150 OTUs for each 
cultivar represented by differing OTUs.  Families containing the same OTUs as the other 
cultivar and showing no differences were indicated as no OTUs of difference. 
Bacteria Family Hanakapi‘ai OTU Papa ‘ele ‘ele OTU 
Xanthomonadaceae 34580, 67341, 81089, 81358, 184325, 
707290, 745642, 1118758, 2195500, 
4343457 
4337890 
Sphingomonadaceae 243129, 1108062, 4447334 150689, 4258048, 4324733, 4344371, 4412910 
Sphingobacteriaceae 357684 544883 
Solirubrobacteraceae No OTUs of difference 240137, 1012112 
Solibacteraceae 204875, 224203, 666038, 812730, 
3292593, 4298720, 4359889, 4361561 
4397941 
Sinobacteraceae 100307, 252012, 685739, 1125638 No OTUs of difference 
Rhodospirillaceae 302726, 1108831, 4298129 240866, 250348, 262768, 4298215 
Pseudonocardiaceae 4351616 918840 
Pseudomonadaceae 270842 544313, 4451011 
Phyllobacteriaceae No OTUs of difference 513360, 795096 
Nocardioidaceae No OTUs of difference 305897, 888357 
Nitrospiraceae 1491 4360284 
Mycobacteriaceae No OTUs of difference 13120, 354851, 736813, 4390723 
Micromonosporaceae 112244, 214718, 248468, 249068 250989, 564025 
Hyphomonadaceae 4468329, 4473304 4290381 
Hyphomicrobiaceae 134163, 235789, 545247, 661494, 
848909, 970359, 1144000, 4326152, 
4337748 
144675, 171619, 210344, 214791, 
222792, 235789, 332595, 822874, 
2727517, 3486915, 4101333, 4327829, 
4354635, 4374806, 4380522, 4433035, 
4477340 
Gaiellaceae 1094433, 1122633, 4310013 244063, 247331, 257531, 311035, 
551344, 561452, 642522, 938901, 
3801733, 3843951 
Comamonadaceae 4453710 153084, 644798, 818450, 819400, 
1148345, 1673321, 4425152 
Chthoniobacteraceae 207973, 224834, 240491, 1109646, 4310127 4350694 
Chitinophagaceae 216350, 632692, 1110791 240838, 1133464 
Bradyrhizobiaceae 4377104 No OTUs of difference 
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 3.5. Discussion 
Direct influence of microbiome upon secondary metabolism has been 
demonstrated in plants of the Cannabis sativa family. An anecdotal example of this is the 
1970’s trend among illicit marijuana producers to allow marijuana to develop an 
associated fungal bloom before recreational use. The influence of the fungal pathogen 
here being to cause a dramatic enhancement of Δ9-tetrahydracannabinol (THC) levels, 
presumably because THC is involved in plant anti-microbial defence responses. A second, 
more systematic study [89] examined soil determinants and cultivar specificity of 
Cannabis microbiomes.  In this study, soil was the major driver of microbial community 
composition (biodiversity), but community structure (relative abundance of different 
microbes) was determined by the plant in the experiment. Cannabinoid diversity and 
composition was significantly correlated to the structure of the endorrhizal communities, 
but this could not be dissociated from soil chemistry.   
So little is known about the microbiome of medicinal plants, as previous research 
has been focused on agriculture for increasing survival and ultimately food yield.  This 
exploratory study was designed to determine microbiome composition, potential 
differences in composition by ‘Awa cultivar, and any differences as a result of traditional 
washing methodologies.  Though differences in moisture content, seasons, time day and 
so many other factors can contribute to differences in bacterial composition, as with other 
soil microbiome studies, this is a snap shot in time of these ‘Awa cultivars and still 
provides a wealth of information.   Additionally, our results strongly suggest further 
studies are warranted in order for us to learn more about the importance of the kava 
microbiome as well as to determine why the similarities and differences that we 
discovered occurred; and more importantly, if and how that affects the secondary 
metabolism or contributes to the overall affect that ‘Awa has on the user.  One area that 
needs to be assessed across all studies of this type is the best way to process the samples.  
Since these replicates are taken from a larger sample, it is quite possible that the 
inconsistency seen in HC.2 and HS.2 are the result of ‘hot’ or ‘cold’ spots that can occur 
in soil sampling as a result of clumps, rocks and other debris that results in great 
differences in the overall shape and size of the particles within the same sample mass 
from which the DNA extraction took place.  Consequently, results for relative abundance 
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run the gamut from higher to lower than other samples.  Environmental studies of semi-
volatile chemical pollutants has reported that depending upon the composition of the soil, 
the mass selected for testing can significantly under- or over-represent the concentrations 
of target compounds; new test methodologies now involve the use of micro-incremental 
sampling that requires pre-processing of samples into similar particle size before 
increments are systemically selected to provide the required mass of analytical testing.  
We wonder if a similar approach to microbiome studies should be employed to better 
determine the composition of bacterial communities, especially for bulk soil samples.  
We also acknowledge that OTUs may or may not represent a different species as 
organisms within the same species can differ genetically in the 16S region V4 rDNA 
region but at the same time we can discount the possibility that they are different 
organisms.   
Previous studies of soil bacteria have shown that the majority of soil microbial 
communities are dominated by Proteobacteria and mostly contain these other phyla: 
Actinobacteria, Acidobacteria, Planctomycetes, Verrucomicrobia, Cytophagales, 
Bacteroidetes, and Firmicutes [109, 110].  For the most part, taxonomy and richness of 
our samples had compositions similar to these with the exception of Cytophagales not 
being present and the addition of small percentages of Chloroflexi and 
Gemmatimonadetes.  The importance of this has not been determined as little is known of 
the soil microbiome composition in Hawai‘i, with the majority of soil studies focusing on 
soil type.  Despite these similarities, distinct differences in phylum composition and 
abundance were noted between the two cultivars: Papa ‘ele ‘ele (PC/PS) and 
Hanakapi‘ai (HC/HS) in both bulk soil and roots samples when compared to the washed 
and unwashed roots of Papa kea (RC/RD). Washed and unwashed samples were 
composed of much higher percentages of Proteobacteria (~80%) while most other phyla 
groups were reduced by at least half compared to Papa ‘ele ‘ele and Hanakapi‘ai samples 
with the exception of Firmicutes. Firmicutes composition remained similar in washed 
samples to percentages seen in bulk soil and roots samples for both ‘Awa cultivars and 
interestingly increased in composition percentage in unwashed samples.  Most likely, 
Firmicutes selectivity by root systems is inherent in their ability to suppress certain root 
rotting fungi [110].  
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With the criticism of the handling of ‘Awa in the commercial setting and the 
question of how that contributed to the toxicity issues previously associated with the 
nutraceutical products, we wanted to look at how washing affects the microbiome on the 
roots.  One area of significant change between the Hanakapi‘ai and Papa ‘ele ‘ele 
samples and the Papa kea washed/unwashed group was the higher proportions of 
Proteobacteria and significant reduction of phyla from bulk soil and rhizosphere 
compared to the endosphere of roots is commonly seen for groups such as Acidobacteria, 
Planctomycetes and Gemmatimonadetes [111], thus in washed samples the near 
elimination of Gemmatimonadetes is consistent; however, unwashed roots still contained 
some rhizosphere soil yet their composition was nearly identical to washed samples 
whereas we expected a little more diversity in these epiphytes leaning more towards the 
composition in root samples of Hanakapi‘ai and Papa ‘ele ‘ele.  What was more 
interesting was the affect root treatment had on the microbiome.  Significant separation of 
OTUs between washed (RC) and unwashed (RD) Papa kea samples were demonstrated 
with selectivity of certain taxa in the family Enterobacteriacaea being greater in washed 
samples, while possibly more important, deselecting for some potentially pathogenic 
species as demonstrated by the loss of Firmicutes: Bacilli in washed samples. However, 
due to the large presence of Enterobacteriaceae on both washed and unwashed roots, it is 
likely the result of contamination as roots harvested and process in non-sterile conditions 
and by hand.  Many traditional practitioners have believed for sometime that ‘Awa has 
probiotic benefits and has been given medicinally to treat gastrointestinal issues (personal 
communication). Additionally, some users of ‘Awa have anecdotally reported stomach 
upset when large amounts of the beverage have been ingest at one sitting, which is a 
common issue for other types of probiotic treatments.  Consequently the presence of 
Enterobacteriaceae bacteria helps to support both observations; however, near elimination 
of these families associated with probiotic bacteria suggests that probiotic benefits are 
from another source, such as how the beverage is made (i.e. reusing and nonwashing of 
the kava bowl and ‘apu). 
Phylum level heatmap showed that Actinobacteria and Acidobacteria were more 
abundant in washed samples then unwashed samples while the Family level heatmap 
showed the greatest selectivity for Enterobacteriaceae followed second by 
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Pseudomonadaceae.  Certain OTUs where greater in abundance in washed samples than 
unwashed samples and included bacteria in the families Xanthomonadaceae, specifically 
Stenotrophamonas geniculata, which has been implicated in the degradation of certain 
terpenoids compounds [112] and may be important in concentrations of kava lactones in 
roots, since terpenoid compounds are precursors to lactones.  On the other hand, some 
Enterobacteriaceae and Pseudomonas bacteria were decreased in washed samples with a 
significant decrease in an OTU identified as P. viridiflava, though not surprising that P. 
viridiflava is reduced on washed roots as it is a known phyto-pathogen that causes 
necrosis in the leaves, stems as well as root rot in food crops [113, 114].  Though not a 
probiotic, P. viridiflava presence is important to growers of ‘Awa in that mild 
temperatures, frequent rain and relative high humidity are optimal conditions for the 
spread of this plant pathogen [113]. In general, Pseudomonas are found ubiquitously in 
the environment and contains the well-studied opportunistic pathogen Pseudomonas 
aeruginosa (Schroeter) found as part of the normal enteric flora as well as in biofilm 
formation [115].  More importantly, some Pseudomonas have also been studied for their 
bioconversion of terpenes into a wide variety of products from chemicals including those 
used in agriculture, antibiotics, antioxidants and anti-carcinogens [116].  Interestingly, 
kava has been studied for its potential as a chemopreventive in lung and bladder cancers 
in terms of the chalcones such as Flavokawain A, B and C and as fractions of the 
ethanoic extract [9, 10, 45, 117, 118], hence further studies should seek to find if there is 
any link between Pseudomonas conversion of certain root chemicals and previously 
report anti-carcinogenic effects.   
With some washed samples showing an increase and other showing a decrease of 
bacteria in these genera, this suggests that ‘Awa roots may select for specific bacteria; 
although the advantage or disadvantage of that is unknown at this time.   More 
importantly, despite the differences between washed and unwashed roots, overall 
traditional washing does not appear to remove most of the bacteria, which may suggests 
that this method of washing exposes the bacteria found in the endosphere and that these 
endophytes may be selected for by ‘Awa exudates.  Studies in other plants have shown 
that the microbiome of plants is strongly influenced by rhizodeposition of plant exudates, 
which can contain sugars, organic acids and a variety of other compounds from hormones, 
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antimicrobials, amino and fatty acids, as well as sloughed dead cells and mucilage, and 
these chemical factors are known to vary significantly between species, cultivars and 
plant age [110].   
Traditional practitioners of ‘Awa use and prescribe different strains depending 
upon the condition or reason; for example, Hanakapi‘ai is often prescribed prophetic 
sleep where answers are sought while Papa ‘ele ‘ele is used to quiet the mind and provide 
a more restful sleep [50].  Many cultivars not only have a different outside appearance, 
but also differ in their chemical composition and concentration of major components like 
the kava lactones [119, 120], so we suspected some variation in the microbiome of our 
two cultivars, Hanakapi‘ai and Papa ‘ele ‘ele.  Instead, we found significant differences 
between the two cultivars as seen in both the phylum and family level heatmaps and even 
between shared OTUs.  Both cultivars contained certain additional bacterial families that 
were consistently strong in abundance across all samples, most of which differed in 
OTUs.  Hanakapi‘ai and Papa ‘ele ‘ele samples also demonstrated possible selectivity 
and de-selectivity of certain OTUs and families by root samples as indicated by higher 
abundances in root samples compared to bulk soil samples and root samples with Papa 
‘ele ‘ele also suggesting a higher selectivity diversity with at least 29 OTUs with some 
level of selectivity compared to Hanakapi‘ai with only 17 OTUs.   Both cultivars also 
demonstrated the possibility of de-selectivity of certain OTUs and families as indicated 
by higher abundances in bulk soil samples compared to root samples. Hanakapi‘ai 
contained three other families with strong to moderate trend for de-selectivity: 
Acetobacteraceae, Hyphomonadaceae and Xanthomonadaceae; however, Papa ‘ele ‘ele 
de-selected for six different families: Nocardioidaceae, Phyllobacteriaceae, 
Rhodospirillaceae, Saprospiraceae, Sphingomonadaceae and Syntrophobacteraceae.  This 
suggests that either Papa ‘ele ‘ele may be more inclined to lower the populations of some 
bacteria in favour of other beneficial bacteria or that this de-selectivity is the reason for 
Papa ‘ele ‘ele samples appearing to be more diverse.   
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CHAPTER 4 
4. CONCLUSIONS AND DISCUSSION 
  
 Primarily, kava research has focused on the kava lactones and their effect on the CNS and 
GABA receptors for its relaxation and anti-anxiety benefits for both the cultural/social beverage 
as well as the nutraceutical supplements.  Results from chapter 2 showed that kava has complex 
cellular responses outside of the CNS/GABA, and that non-kava lactone components initiate 
other cellular responses, especially those associated with calcium ion channels, TRP and ICRAC. 
These results indicate that a strong and important connection between non-kava lactones and 
some of the documented physiological as well as potential pathophysiological responses.  These 
secondary metabolome products are understudied, not only in kava, but also in other potential 
medicinal plants, to include C. sativa, which is used here as an example.  Cannabis contains 
more than 400 known bioactive molecules, but knowledge of their mechanistic action is 
extremely limited as the focus has been primarily on the cannabinoid compounds [48, 49].   
 In the case of kava, the focus has been on the kava lactones due to their high 
concentrations (96%) in extracts [36]; however, the remaining concentration contains a plethora 
of other kava components, which include the dihydrochalcones (flavokawains A, B and C), 
flavanones  (5,7-dimethoxyflavanone, 5,7-(OH)2-4-one- 6,8-dimethylflavanone, 5-hydroxy-4’,7-
dimethoxyflavanone), chalcones (pinostrobin chalcone), and tentatively identified compounds in 
the classifications of phenolics, and fatty acids (8,11-octadecadienoic acid-methyl ester) as well 
as cinnamic acid bornyl ester [8].  The latter, cinnamic acid, is a known transient receptor 
potential (TRP) channel activator, specifically TRPA1 in mast cells, which is associated with 
contact dermatitis [39, 40] and thus the potential receptor and associated molecule that may be 
responsible for the kava dermopathy.  Another TRP channel, TRPV, are stimulated by chemicals 
such as capsaicin and are responsible for the burning sensation felt from hot peppers [121], with 
this suggesting that a related kava component may be responsible for the tingling sensation 
associated with the kava root/beverage.  Other TRP channels are potential targets of kava 
secondary metabolites and based on their locations and non-responses and may also explain 
some of the efficacy and possible toxicity, specifically, TRPP, found as membrane bound 
proteins on tissues such as the kidneys, may be a link to the kidney and liver toxicity; TRPA 
channels, associated with apoptosis [121], may explain cellular tissue damage as well as the 
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potential mechanism for anti-carcinogenic properties briefly mentioned in the introduction.  
Chapter 2 results strongly suggest that the kava-lactone-centric viewpoint, which is not to say 
that these responses are not equally important, under estimates the impact of other cellular 
responses on efficacy and potential toxicity.   
 With the emerging evidence that kava has a wide-range of secondary metabolites, but 
also based on the results of chapter 2, contain a number of bio-active molecules that induce non-
CNS/GABA targets, it is important to look at factors that impact the production kava 
phytochemicals.  On such important factor is the microbiome of the plant and surrounding soil; 
in fact, studies on C. sativa have shown that the microbiome influences changes in metabolic 
products to include THC levels.  Combined with the traditional practitioner knowledge that 
different growing locations/conditions influence the properties of the kava cultivar, which results 
in how they use and prescribe the strains, suggests that the microbiome may play an important 
role in the differences in metabolite production.  In order to dive into these concepts, a general 
study into the microbiome of the plant and surrounding soil needed to be addressed, and here, in 
chapter 3, we undertook the challenge of describing the first kava microbiome.  Compared to 
other published soil microbiome results, no discernable revelations were made outside of slight 
differences in soil phylum composition; however, prior to this, studies on Hawai‘ian soil have 
focused on physical and chemical characterizations for agricultural purposes.   
 On the other hand, comparisons between Hanakapi‘ai and Papa ‘ele ‘ele cultivars did 
reveal significant differences in their microbiomes that may help to later explain the important 
distinctions in the properties of these two cultivars.  For starters, family level comparisons 
showed an overall difference in abundance and composition with Papa ‘ele ‘ele generally lower 
in abundance values but slightly more diverse than Hanakapi‘ai samples.  Furthermore, many 
more OTUs representing these families were more strongly represented in Papa ‘ele ‘ele bulk 
control soil and root samples suggesting that this cultivar is either less selective of bacterial 
species, or possibly, the plant is less influenced by the microbiome.  Also, Hanakapi‘ai and Papa 
‘ele ‘ele were represented by some differing families in the top 150, seven and eight different 
families respectively.  Interestingly, even within shared families, each cultivar was either 
represented by different OTUs, or in some cases, in a higher number of OTUs affecting the 
percentages in which these families were represented in each cultivar.  Overall, at the OTU level, 
despite a general similarity in sharing most family categories, Hanakapi‘ai and Papa ‘ele ‘ele 
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share few species with each other.  The importance of this cannot be determined from what we 
currently have discovered in chapter 3; nevertheless, these results strongly suggest enough 
differences to have a potential effect on important pathways associated with the generation of 
secondary metabolites and even the concentrations of the kava lactones.   
 In chapter 3, at the request of the kava community, we also investigated the affect that 
washing techniques have on kava roots of Papa kea, as well as, the potential that kava is 
probiotic.  Unwashed roots (with soil brushed off) as well as power washed roots did show 
significantly lower phylum level richness and concentrations compared to Hanakapi‘ai and Papa 
‘ele ‘ele root samples, but washing did not removed most or even all of the microbiome 
suggesting that endophytes within the root interior are exposed.  Results in chapter 3 also 
indicated that both washed and unwashed Papa kea samples did associate with known-gut 
bacterial families with at least one OTU in the family Enterobacteriaceae higher in abundance on 
washed samples.  However, due to the large presence of this family (54%), it may be the result of 
contamination since it is standard for kava roots to be processed by hand and under non-sterile 
conditions.  Despite this, it does appear that at minimum, washing does remove most potentially 
pathogenic species.  In terms of probiotic impact, results did show that families associated with 
probiotic species do associate with roots, but washing nearly eliminates these bacteria; as a result, 
any probiotic benefits attributed to kava must be the result of how the drink is later prepared such 
as re-using and not washing of the kava bowl and the ‘apu.  Of potential agricultural importance, 
Papa kea results did show that a few plant pathogenic species do associate with the roots, most 
notably P. viridiflava, which causes root, stem and leaf necrosis, and genus Erwinia, which is 
associated with blight.  This is important to kava growers since new plants are developed from 
the stocks of previous generations, so care must be taken to avoid spreading and contaminating 
the next generation of kava plants and soil as well as avoiding soils or treating soils for these 
pathogens prior to planting.    
 On a final note, the success of this project could not have been completed without the 
support and sharing of the kava community.  It is imperative that the scientific community 
embraces and values the knowledge of traditional practitioners for the wealth of understanding 
through their generations of working with and learning from the kava plant.  To attempt to do so 
without them places the scientific community in a knowledge gap that will continue to place the 
public at risk.  This must be applied to other natural product plants as well, as Western medicinal 
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industrial complex as well as the consumer continue to search for alternative treatments to 
combat the array of side effects and perceived greed associated with pharmaceutical drugs and 
industry.  Working together as partners, will create more understand about these plants as well as 
build appreciation for them, for not only there complexity, but there importance in traditional 
society, and together, these two communities will able to solve problems and health concerns on 
both sides of the spectrum. 	 	
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geographical perspectives
Piper methysticum Forst. f., meaning, “intoxicating pepper,”
is a shrub-like plant known predominantly as kava, or `awa to
theNativeHawaiians. It is native toOceania, growing throughout
Polynesia, Melanesia, and Micronesia [1]. The plant was domes-
ticated ~3000 years ago in Vanuatu, and spread throughout
Oceania via Austronesian colonists [2]. In the Native Hawaiian
culture, `awa is described as coming to Hawai`i with the akua
(gods) Kāne and Kanaloa. Kāne is believed to have made water
appear to nurture the `awa crop.
Traditionally, the consumption of kava as a beverage
was sacred in Pacific cultures. Indeed, in the words of Mary
Kawena`ulaokalaniahi`iakaikapoliopelekawahine`aihonuaināle
ilehuaapele Pukui “…..`awa was the food of the gods…….no
religious ritual was complete without it” [3]. Offerings of `awa
weremade to protect thehealth of theHawaiianpeople, in rites
of passage, to lift tabus and to both facilitate consensus-
building and prepare for war or battle. Margaret Titcomb [4]
summarized usages of `awa: “The `Awa custom is of interest in
Hawai`i because it was a sacred drink of importance in many
phases of Hawaiian life.… Its effect is to relax mind and body…..
Medical kahunas (learned men) had many uses for it…..It was
essential on occasions of hospitality and feasting, and as the drink
of pleasure of the chiefs”. A Hawaiian mele illustrating these
usages is shown at the left.
Various parts andpreparations of `awawere usedmedicinally
in Pacific cultures. From their earliest contact with Pacificislanders, Europeans were therefore interested in kava as a
medicine, first as a treatment for venereal diseases [5], and
later as a sedative and treatment for anxiety [2]. A major boom
in kava popularity occurred in the 1990s linked to both health-
related and recreational usage for non-Pacific audiences. The
most recent incarnation of the kava story is as a nutraceutical,
formulated as pills and liquid extracts, as an analog to anti-
anxiety drugs. Products are standardized to a specified concen-
tration of kavalactones, which have been extracted from kava
plant material with alcohol, acetone, or water.2. Contemporary exposures to Kava
In the contemporary Pacific, people still drink kava. The
drink is still prepared in a semi-traditional manner as a water
extract served from a common bowl into smaller drinking cups
(often coconut shells). The drinking protocols and associated
social meanings continue to evolve. There is an awareness
of the traditions associated with kava, even if little of this
knowledge is incorporated into the actual way the beverage
is consumed. The purpose of contemporary consumption is
largely consonant with less formal consumption of earlier
times, but the frequency of consumption, amount consumed,
and social context of kava drinking also reflect modern shifts
in perspective and social relations. Current exposure is in
some cases significantly different from that in the past. As
such, a review of kava's safety should examine these shifting
and nuanced social dynamics, rather than reiterating past
dichotomies of traditional/nontraditional consumption [6].
Contemporary kava use presents two distinct patterns of
consumption. Kava drinking is social, involving relatively high
doses, and the dosage is not strictly controlled or limited.
Kava nutraceutical consumption is of a fixed recommended
daily dose for the goal of treating a specific medical condition; it
is personal rather than social. Traditionally, kava is mixed with
water, is not extractedwith another solvent, is strained by hand,
and is prepared as a social drink. By contrast, nontraditional
nutraceutical forms of kava are solvent-extracted (alcohol or
acetone), usually as part of a commercial process, and not
consumed socially. A full description of traditional kava drinking
and nontraditional consumption is beyond the scope of this
paper [2,6], but there are some salient points for comparison
when thinking about dosage, effects, and possible risk from
these different consumption practices. First, the amount of
kava consumed by drinkers is significantly higher than that
consumed by those taking supplements. Kava drinkers will
normally consume several coconut shells of kava beverage in
a typical drinking session. On average, each shell contains as
much more than the recommended daily dose of kavalactones
used in supplement form for treating anxiety (~200 mg). A
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could easily be in the range of 1.0–1.5 g. It should be remem-
bered that these two forms are not identical, as they are pre-
pared by substantially different techniques, and using different
solvents. Second, kava drinking is a social activity, whereas
supplement consumption is a personal activity with no inherent
social dimension. Third, kava beverage is not a standardized
product, whereas nutraceuticals supposedly are.
It is difficult to accurately determine the number of people
who are consuming kava, the amount of kava they are taking,
and the frequencywithwhich they use it [7]. Global use of kava
supplements is certainly substantially lower than it was in 2001,
prior to bans instituted by several countries due to concerns
about liver toxicity [8–15]. However supplement use in the US
continues; consumption of kava as a social beverage seems to be
increasing [16–23]. Data on the amount of kava produced and
exported are not accurate, sales figures for kava products are
not widely available, and it is difficult to estimate number of
users since both the production and consumption sides of the
commodity chain are fragmented.
Kava is grown in more than 6 different island nations in the
Pacific and in thewider Pacific Islander diaspora. It is consumed
locally and exported to the United States for manufacture into
nutraceuticals. Fiji, Vanuatu, Samoa, and Tonga are primary
kava-exporting countries [24]. Export statistics from the pro-
ducer nations give a partial glimpse of consumption, but they are
not widely available or reliable. The decentralized, minimally
regulated nature of kava's commodity chain contributes to this
uncertainty. With respect to supplement use, several companies
produce kava supplements (andother products such as kava skin
creams), primarily for the US market. There is the potential for
this market to dramatically increase, following a 2014 court
decision inGermany that overturned thebanonkava products in
that country. Changes such as this to the regulatory frameworks
inwhich kava is embedded could quickly affect the availability of
these products.
Kava consumption in the US has expanded through sup-
plement availability and most recently through the proliferation
in kava bars. In the Pacific, there have also been changes in the
pattern of kava consumption. Migration within the region has
brought kava drinking to places where it was not previously a
tradition (e.g., Kiribati, New Caledonia, the Solomon Islands, and
NewZealand; see [6,25]). In addition, changing social practices in
societies for which kava drinking is a traditionmay be leading to
increased consumption. For example, more women are drinking
kava in the Pacific than in previous decades. The aggregate result
is more demand for kava for general consumption, and more
kava consumed in those drinking sessions, as well as an increase
in growing kava [26]. In light of these points, a review of the
potential toxicity of kava is timely.
3. Kava pharmacology and targets of action
The known active ingredients in kava are the kavalactones.
Eighteen of these have been identified, but only six of them:
methysticin, dihydromethysticin, kawain, dihydrokawain,
desmethoxyyangonin and yangonin, have been the focus of
kava studies as they make up 96% of organic extracts [27].
See Fig. 1 for structures of major kava components. However,
kava extractions contain a variety of other non-lactone com-
pounds, which may be responsible for the pharmacologicalbenefits and potential toxicity [27,28]. The activity of kava
may be the result of one of these non-lactone compounds or
a synergy of several or all components found in kava. In fact,
studies on RBL2H3 mast cells (Rat Basophilic Leukemia subtype
2H3, ATCC CRL-2256), showed that traditional aqueous kava
extracts elicited strong calcium responses not seen in individual
or combined purified kava lactones, specifically methysticin,
dihydromethysticin and kawain [29]. Furthermore, traditional
aqueous kava extracts demonstrated mast cell degranulation
whereas purified lactones did not [29].
A focus on kavalactones may neglect other important com-
pounds in kava that can direct cellular responses. Additional kava
components include the dihydrochalcones (flavokawains A, B
and C), 5,7-dimethoxyflavanone, cinnamic acid bornyl ester as
well as tentatively identified compounds classified as phenolics,
flavanones, fatty acids and a chalcone, specifically 2,5,8-
trimethyl-1-naphthol, 5-methyl-1phenylhexene-3-yn-5-ol,
8,11-octadecadienoic acid-methyl ester, 5,7-(OH)2-4′-one-
6,8-dimethylflavanone, 7-dimethoxyflavanone-5-hydroxy-
4′ and pinostrobin chalcone [28]. Cinnamic acid has been
shown to activate the mast cell calcium channel TRPA1 and
has been associated with contact dermatitis [30–32] while
the pinostrobin chalcone can act as a stimulatory or inhibitory
molecule on mast cells [33]. Equally important, the type of
extraction solvent used has a marked effect on the ratios of
these compounds as well as the kavalactones, with some
compounds not being extracted at all [28].
Though studies have focused on the kavalactones being the
primary components of kava extractions, correctly since they
have demonstrated amechanistic connection to gamma amino
butyric acid (GABA) receptors, the chemical complexity of kava
extracts suggests that a kavalactone-centric approach may
(1) underestimate the complexity of and (2) not provide a
mechanism for some of the non-GABA based medicinal effects.
4. Kava side effects
Controversy between the approaches of Western kava
use and its traditional counterpart arises when considering
its medicinal role and the possible pathological side effects
on human physiology [34,35]. The pathophysiological effects of
kava include muscle degradation, kava dermopathy presented
as scaly skin rashes, urticaria, sebotropic eruption, menin-
gism, depression/suicidal tendencies and hepatotoxicity
[11,13,36–44]. Amongst traditional practitioners, chronic use
of kava has been associated with exfoliating dermopathy
[13,36,37,40] that is acknowledged as common. However, long-
term health effects such as hepatotoxicity and carcinogenic
activity are generally and historically unknown in these same
Pacific cultures. Whether this is the result of underdiagnosis,
generally poor health surveillance or genuine protection against
adverse affects (via genetics, usage patterns or preparative
methods) is a crux of current debate. Conversely, the adverse
events reported in the Western scientific literature may reflect
preparations, material origins and co-morbidities with alcohol,
other supplements or prescription drugs that are not dominant
in Pacific cultures.
Concerns about possible toxic effects of kava arose in
Western countries when reports fromGermany, Switzerland
and the United States allegedly linked the use of kava con-
taining productswith liver failure [45,46]. From1999 to 2002, a
Fig. 1. Kava constituents discussed in the text.
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two in the U.S. required liver transplants after using products
containing kavalactones at doses ranging from 60 mg to 240 mg
for as little as 8 weeks to as long as 12 months [9,11,13,41,47,48].
Both patients in the U.S. reported taking kava supplements in
capsule form while most European patients reported kava
prepared by extraction with either acetone or ethanol [41]. CDC
advisories were released in 2002 and 2003 [15,41]. Due to
potential toxicity, kava was banned in 2002 by the German
Federal Institute for Drugs and Medical Devices (BfArM) and
the British Parliament followed suit banning the sale of all
products containing kava in 2003 [8–13,49]. However, on June
10, 2014, the German Administrative Court overturned the 2002
ban reinstating the regulatory requirements of 2001. This
court stated that risk from kava exposure has not been clearly
demonstrated nor appears unusually high, an opinion presum-
ably driven by the very small number of cases of reported
toxicity (n ~ 3) with even a certain degree of causality linked tokava in a global kava-consuming community that may number
in the millions of doses consumed daily.
As we review below, Western science has reported inconsis-
tent information with some studies showing human kava use
with hepatotoxicity ranging from cirrhosis, hepatitis and even
liver failure [9,11,13,41,47] and some which do not [50–52]. A
range of side effects and adverse effect outside the liver are
suggested by human cases and animal studies [34,35]. Animal
studies demonstrate carcinogenicity of kava, and yet chemopre-
ventive actions, creating a confusing picture for consumers and
health professionals. One question which is little addressed in
the literature concerns whether under-reporting or diagnosis of
health conditions contributes to the perception that kava is not
dangerous in the Pacific. This is a clear critique of the work of
Steiner which is oft-quoted as an epidemiological basis for the
cancer-preventive effects of kava, and by extension as a logic that
kava in the Pacific ‘does no harm’ [53]. The Steiner study draws a
correlation between kava use and ‘low’ cancer rates in Pacific
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and alternate explanations, and the high potential for under-
reporting/under-diagnosis of cancer rates in Pacific island
societies with challenges in health care access and provisions
such as pathology services. Absent more evidence, the Steiner
study is an exemplar of the cum hoc ergo propter hoc (Lat., with
this, therefore because of this) class of epidemiological fallacy
where association cannot be used to infer causation.
Pacific practitioners address the apparent paradox (the
toxicity associated with ‘Western’ use but not in indigenous
cultures) through drawing attention to differences in extraction
method, uninformed use of particular cultivars or ill-advised
production of the kava drink from parts of the plant not in
traditional use. This paradox, together with the explosion of
relatively uncontrolledmixes and preparations of kava cons-
tituents in the nutraceutical market and a concomitant increas-
ing deviation from traditional preparative methods, creates a
need to: (1) review the depth and strength of current data on
toxicity, (2) reconcile the apparent paradox between the
Generally Regarded as Safe (GRAS) status of traditionally pre-
pared beverages in Pacific cultures with studies and clinical
experiences that suggest toxicity, and (3) develop recom-
mendations informed by traditional practices that support safe
exploitation of the potential medicinal and nutritional benefits
of kava and its many bioactive components.
5. Recent progress in kava toxicology
Here, a range of studies is reviewed across in vitro and in vivo
systems that examine the toxicity of kava and kava components
in aqueous and organic preparations.
5.1. National Toxicology Program study
A comprehensive toxicology study in rodents was performed
the by National Toxicology Program (NTP) and published in
2012. This was a 2-year kava gavage study in F344/N rats and
B6C3F1 mice. The study revealed equivocal evidence of carcino-
genic activity among male rats, and clear evidence of carcino-
genic activity in male mice with some evidence of carcinogenic
activity in female mice. In addition, kava extract in male and
female rats resulted in an increase of tumor-like lesions in eyes,
kidneys, liver, pancreas and rumen.Note that Equivocal Evidence
is defined as marginal increases in neoplasms that may be
chemical related, and Some Evidence is defined as a chemical-
related increase of malignant, benign or a combination of
neoplasms with a response in strength less than that defined
under the NTP guidelines for Clear Evidence of carcinogenic
activity [54].
The bulk powdered kava extract used in the NTP study
(Cosmopolitan Trading Co.; Seattle, WA; Lot 9077SDK) was
tested for purity, stability, organic constituents, and identity
using various chromatographies. Methanol and aqueous extrac-
tions tested by HPLC/UV and LC/MS identified six kava lactones
present in the powdered extract: methysticin, dihydro-
methysticin, kavain, yangonin and desmethoxyyangonin.
LC/MS tentatively identified seven additional compounds.
Cadmium, lead, mercury, organchlorine and organophospho-
rous pesticide contaminants were below detectable limits. The
bulk kava extract contained 1.4 ppb N-nitrosodimethylamine(NDMA) and 31.2 ppbN-nitrosopyrrolidine [54], both of which
can be hepatoxic in rodents at 1 mg/kg levels [55].
A three-month studywas designed todetermine any additive
toxic effects to kava exposure and determining best concentra-
tions for a two-year study. Upon terminal sacrifice no gross
lesions were observed but both liver weights were increased in
all male rat groups and in at some female rat doses. Microscopic
visualization showed hepatocellular hypertrophy in female
groups. Malemice in some dose groups displayed centrilobular
hypertrophy. Absolute liver weights were significantly
increased and male rats at week 14 showed a decrease in
alkaline phosphatase (ALP), alanine aminotransferase (ALT),
and sorbitol dehydrogenase (SDH). Both male and female
2.0 g/kg rats showed a significant increase in cholestasis
serum marker γ-glutamyltransferase (GGT); however, all other
cholestasis markers were either decreased or unaffected [54].
In the two-year core study, lethargy and lack of muscle
control occurred within the first four weeks of the study; these
incidences appeared to decrease in the number of rats over
time but reappeared periodically through the remainder of the
study at this same dosage. Around the first year of the study,
some rats experienced seizures. Hematology results in both
male and female rats also showed a decrease in ALP, ALT and
SDH and increases in cholestasis markers γ-glutamyltransferase
and bile salts [54]. Unlike the 3-month study groups, ‘statistically
significant or biologically noteworthy’ tumor and/or tumor-like
lesions appeared in the two year study [54]. An increase in the
prevalence of hepatocellular hypertrophy and instances of fatty
change [54] were observed in liver [56]. Cystic degeneration and
significant increases in multiple hepatocellular adenomas were
observed. Malignant liver tumors significantly increased in male
mice (in the form of hepatoblastomas) and increased in all kava-
exposed female mice (in the form of hepatocellular carcinoma).
Male and female mice displayed a significant increase in centri-
lobular hypertrophy and hepatocellular necrosis [54].
Other organs also showed changes after kava exposure.
Significant increases in inflammation, formation of ulcers
and increased growth in epithelial cells were seen in the fore-
stomach. Increases in kidney damage, transitional epithelial
hyperplasia of the renal pelvis, parathyroid gland and in the
bone marrow hyperplasia and retinal degeneration were
observed. Leydig cell and bilateral interstitial cell adenomas
occurred and kava dose correlated with increase in severity
of hyperplasia. Microarray data and immunohistochemistry
examined any possible mechanisms for the liver toxicity seen in
the animal studies. These tests showed that kava alters cyto-
chrome P450 family of drug metabolizing enzymes (specifically
CYP1A1) dose-dependently [54].
In summary, evidence from the NTP studies showed that
kava exposure impacts liver function and is most likely dose-
dependently and chronically toxic as demonstrated by the
significant increases in GGT concentrations, hepatocellular
hypertrophy and other histological observations in the three-
month and two year studies as well as the effects seen on P450
liver enzymes. Liver toxicity did occur in both rats and mice.
Despite the differences in tumorigenesis noted between the
animal species, the conclusion of the two-year study stated that
“there was equivocal evidence of carcinogenic activity in male
F344/N rats based on marginal increases in the incidences of
testicular interstitial cell adenoma”, “clear evidence of carcino-
genic activity of kava kava extract in male B6C3F1 mice based on
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carcinogenic activity of kava extract in female B6C3F1 mice based
on increased incidences of hepatocellular adenoma or carcinoma
(combined)” [54].
5.2. Flavokawain B is a hepatotoxic constituent from kava root
Chalcone kava components have been linked to the hepato-
toxic effects seen in kava consumption [51]. HepG2 hepatoma
cells exposed to ethanoic extracts of the kavalactones shown
to contain kawain, dihydrokawain, methysticin, dihydro-
methysticin, yangonin and desmethoxyyangonin separately
via HPLC showed no toxicity at 150 μMwith the exception of
yangonin demonstrating an LD50 toxicity at 100 μM; whereas,
kava root extracts containing Flavokawains A, B and C (FKA,
FKB, FKC) showed significant toxicity. FKB showed the highest
in vivo toxicity with an LD50 value of ~15 μM, and inhibited
NFκB activity in vitro. These results suggest that, for the most
part, the kavalactones are not the source of toxicity with only
yangonin being weakly toxic [51]. FKB hepatotoxicity was
confirmed in vivo when male ICR mice were fed 25 mg/kg
bodyweight FKB for oneweek. FKB fedmice showed substantial
liver damage (hepatocellular swelling, vesicles appearing in
the cytoplasm, and inflammation in the periportal area). These
results strongly suggest that FKB is hepatocellular toxin not
only in vitro, but also in vivo [51].
These studies demonstrate that kava has potential toxicity
in both in vitro and in vivo models, yet understanding of the
mechanism involved in kava toxicity is unclear. Several mech-
anisms have been proposed that may explain not only the
toxicity seen in the above models as well as in the few human
cases, but alsomay explainwhy the toxicity is reserved to a small
number of individuals andwhy this same toxicity is not observed
in Polynesian populations.
6. Mechanisms of toxicity
6.1. Importance of the P450 enzymes and the effect of kava on CYP
genes
Inhibition or other defect in CYP genes or direct inhibition of
the P450 enzymes is of concern when ingesting any chemical.
Approximately 1% of Polynesian and nearly 1% of Asian pop-
ulations have CYP2D6 deficiency; whereas, approximately 6% of
Western Europeans and up to 9% of Caucasians are CYP2D6
deficient [54]. Some studies have suggested that kava toxicity in
humans is due to a deficiency in the CYP2D6 gene, responsible
for coding the cytochrome P450 family of oxidase enzymes
[57–59]. In vitro experiments have shown inhibition of several
CYPs when exposed to kava extracts and kava alkaloids; it
is believed that this inhibition increases the possibility of
cytotoxicity due to drug interactions when both kava and other
chemicals are consumed concurrently [58,60]. Methysticin
analogs found in kava contain a methylenedioxyphenol group,
which aftermetabolism, demonstrated inhibition of several P450
enzymes. Kava extracts, normalized to 100 μMkavalactoneswith
NADPH, severely inhibited CYP2C9, CYP2C19 and CYP3A4. Of the
individual kavalactones, desmethoxyyangonin showed sig-
nificant inhibition of CYP2C9 and CYP3A4. Methysticin showed
inhibition of CYP2C9, CYP2D6 and CYP3A4; dihydromethysticin
inhibited CYP2C9, CYP2C19, and CYP3A4. However, kawaindemonstrated no inhibition of these families of P450
enzymes [58,60]. Thus, inhibition of P450 enzymes by kava
may be responsible for drug interactions and liver toxicity; and
desmethoxyyangonin, methysticin and dihydromethysticin may
be competitive inhibitors of P450 enzymes [58].
6.1.1. Inﬂuence of extraction method on kava toxicity
The bioavailability of kava components varieswith extraction
conditions [27,28]. Nutraceutical production of kava products
favors organic extraction methods over the traditional water
extraction, because they result in higher concentration of
kavalactones than aqueous extraction [8]. Analyses comparing
water-extracted kava to acetone, ethanol or methanol extrac-
tions have demonstrated differences in the kavalactone ratios
and representation of polar compounds [27,28]. Despite these
differences in extractionmethods, it is still unclear if kavalactone
overdose per se is the root cause of any toxicity. However, the
elevated levels of kavalactones in organic extracts (especially
those that are over-represented relative to traditional aqueous
preparation) are often pointed to as a potential source of toxicity
in organic/nutraceutical preparations. It should also be noted
that carbon dioxide extraction is used in some nutraceutical
preparations, but the chemical profile of extracts from this
methodology is not published, and their relative efficacy/toxicity
has not been studied comparatively in in vitro or in vivo systems.
6.1.2. Genetic inﬂuences on kava toxicity
CYP2C9, CYP2C19 and CYP2D6 are the most polymorphic
CYP [61]. Drug metabolism is either classified as monogenic, or
polygenic, or polymorphic (a monogenic trait that has two or
more phenotypes and genotypes in a population) variations that
result in individual differences in drug metabolism. Individuals
are poor, extensive or ultrarapid metabolizers (PM, EM, UM).
PMs have a deficiency in drug metabolizing enzymes, which
leads them to increased risk of toxicity due to drug accumulation
of both the active compound aswell as anymetabolites [62]. EMs
and UMs, though able to quickly metabolize drugs have their
own concerns in that therapeutic benefits of such compounds
may require higher doses making determination of safe levels of
any drug for an entire populous difficult to determine.
CYP2D6 (debrisoquine/sparteine hydroxylase) is believed
to metabolize at least 25% of all common drugs [61]. The gene
locus is polymorphic with at least 70 allelic variants. Variant
D6 alleles (most notably D6*2, D6*4, D6*5, D6*10, D6*17
and D6*41) are responsible for poor, normal and extensive
(ultra) metabolizer phenotypes as well as completely
annulled activity [61]. Genetic differences in CYP2D6 genes
between traditional-kava drinkers of Polynesian decent versus
nutraceutical-kava users of non-Polynesian decent, have been
hypothesized as a possible cause of the kava toxicity in a few of
the previously reported cases [63]. In two cases of toxicity, the
patients tested as CYP2D6-deficient [8,11]. Differences in ability
to metabolize racemers of drugs may also link to CYP genotype.
For example, CYP2C19 metabolism of S-mephenytoin EMs
are identified as those able to completely hydroxylate the S-
enantiomer with PMs showing a deficiency in the ability to
undergo this reaction [62,64].
Differences in polymorphic CYP enzymes may affect the
functionality or toxicology of Western medicines and nutra-
ceutical alternatives. Moreover, the dominance of these genes
inmixed ethnic individuals is not clearly understood, indicating
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be higher than previously reported. For example, the incidence
of debrisoquine (CYP2D6) PMs in the New Zealand Maori
population consisting of mixed racial backgrounds primarily
with Caucasian lineage has been reported at 5% and proguanil
(CYP2C19) PMs at 7%, suggesting that mixed genetic back-
ground is extremely important in the drug metabolism [64].
Due to the origination of South Pacific Polynesians from
Southeast Asia, both CYP2D6 and CYP2C19 polymorphisms
were studied in unrelated South Pacific Polynesian volunteers
and compared to the known polymorphisms in Asians and
Caucasians [64]. Volunteer Cook Islanders, Niueans, Samoans
and Tongans ranging in ages from 18 to 47 years and of at least
75% Polynesian heritage were given 10 mg of debrisoquine
sulfate for the CYP2D6 study after overnight fasting. Of the 78
subjects who classified themselves as 100% Polynesian and the
22who classified themselves as 75% Polynesian, the incidences
of debrisoquine PMs were reported at 0% ± 3.6% with
metabolic ratios values from 0.01 to 9.94 [64].
In a proguanil study, 33 females and 26 males from the
original group (ranging in ages from 18 to 44) were given
200 mg of proguanil hydrochloride, one week after the
debrisoquine study and collected for 8 h and tested using the
same protocol above; only the antimode metabolic ratio of
proguanil:cycloguanil above 10 (log10 = 1) indicated PMs.
Of this group, eight subjects (five of 100% Polynesian decent,
two of 25% Chinese descent and one of 25% Caucasian decent)
were classified as proguanil PMs or 13.6% of the subjects with a
95% confidence interval of 5.9 ± 24.6% with metabolic ratios
from 11.1 to 34.4. Compared to EMs, PMs excreted approx-
imate 50% less compared to the amount given orally. The
results of these studies showed that Polynesian subjects have a
closer resemblance of CYP2D6 and CYP2D16 polymorphisms to
that of Southeast Asian populations than to Caucasian popula-
tions, which may contribute to differences in kava metabolism
and toxicity in Polynesian kava users [64].
The effect of mixed and/or Polynesian ancestry on the
rate of CYP polymorphisms within a population has not been
studied. Native Hawaiians, for example, have intermixed with
many other populations such as Asians and Caucasians, and the
prevalence of genes responsible for UM, EM and PM pheno-
types is unknown. Diminished CYP2D6 functionality in Mexican
American populations may provide a useful analogy that we can
use to illustrate the potential for similar polymorphisms in Pacific
populations. Mexican Americans (MA) have a diverse American
Indian, Spanish, African, Caucasian genetic background and 2.6%
of the population was classified as PMs [65]. Within the Native
Hawaiian community, the results of an influx of Caucasian and
other genes since the late 1700s may have affected the CYP2D6
polymorphisms of this population originating from those of
Polynesian decent.
6.2. Drug interactions
Kavalactones inhibit several P450 enzymes, and as a
result they could interact with drugs and herbal supple-
ments. In addition to pharmacokinetic interactions, kava
may have the potential to cause pharmacodynamic interac-
tions as some of the lactones have exhibit the ability to
obstruct gamma-aminobutyric acid (GABA) receptors and
both sodium and calcium ion channels [66]. Several drugsand drug categories have been reviewed for their potential
interactivity with kava:
Kava is known for its calming and sedating effects and as
such concerns arose to its potential to interact with central
nervous system depressants such as alcohol, barbiturates
and benzodiazepines [57,66]. Interactions with kava and
alcohol have been reported in both mice and human
subjects. In humans, the effect of kava (1 g/kg powder in
500 mL water) and alcohol (0.75 g/kg) both alone and
together was tested on cognitive performance of 10
subjects. When both kava and alcohol were co-consumed,
impairment was noticeably increased [57,66]. Interactions
with Levodopa, aspirin and warfarin have also been
proposed [57].
Interactions with kava and other herbal products are of
potential concern. Several of the cases reviewed for kava
toxicity have also indicated that St. John's Wort was co-
ingested including one of the CYP2D6 deficient patients and
a case involving an approximately 68-year-old woman
presenting with cholestatic hepatitis [8]. St. John's Wort has
shown inhibition on CYP enzymes, specifically intestinal
CYP3A4. Moreover, St. John's Wort extracts in the U.S.
must contain at least 3.0% hyperforin, and this compound
interferes with the uptake of serotonin, norepinephrine
and most importantly, dopamine [22,66]. Consequently,
St. John's Wort is a potential inhibitor of any drug that
affects these important brain neurotransmitters and since
kava has also demonstrated inhibition of dopamine, they
may well interact.
Even dietary foods and drinks can have interactions with
medications or other supplements. For example, IC50 values
for kavalactones at CYP1A2, 2C9, 2C19, 2D6, and 3A4
resemble those of the grapefruit components bergamottin,
6,7-dihydroxoybergamottin and naringenin [60,57], and
thus there is the potential for interactions of kava evenwith
everyday ingestants.
6.3. Enantiomers of kava components and toxicity
Many biological structures and processes differentiate
between chiral compounds. Enzymes, receptors and trans-
porters have enantiomeric specificity. Chiral drugs are proc-
essed by biological systems imbued with this enantiomeric
propensity and the pharmacokinetics and toxicity of enantio-
mers differ [67]. Kawain, dihydrokawain, methysticin and
dihydromethysticin are chiral compounds [8]. The kava-
metabolizing CYP2C19 shows enantiomer (metabolizing S
faster than R) preference for mephenytoin, an anticonvulsant
[62]. Some commercially available kava treatments add a
racemic synthetic kawain, which is thought to increase activity
but may instead increase toxicity [27]. Despite concerns that
racemic lactones like kawain may be responsible for the
toxicity of commercially prepared organic extracts, studies
addressing this issue seem to be non-existent (to date). One
study examined pharmacokinetics of naturally occurring (+)-
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by naturally occurring kavalactones, but did not look at the
effects of the other enantiomer [59].
Stereospecificity of enzymes in both the activation and
elimination of chiral pharmaceutical drugs is critical in pro-
viding safe effectivemedications. In the absence of explicit kava
studies on chirality, we can look to other traditional medicines
for analogous studies:Wang and Zeng (2010) reviewed several
studies that focused on Traditional Chinese Medicines (TCM)
that contain at least one chiral center, which may also give a
glimpse into the pharmacokinetics of the chiral components
found in kava [67]. The first group, the citrus flavonoids
(flavonones), contains a chiral carbon within a ring structure,
which can undergo non-enzymatic conversion from one enan-
tiomer to the other or racemization from optically active
to inactive. Of these, three flavonones were tested in rats for
their pharmacokinetics: hesperetin, naringenin and eridictyol.
Hesperetin and naringenin enantiomers were metabolized
differently [67,68].
The L-(-)-form of an alkaloid, tetrahydropalmatine (THP)
from Cordyalis yanhusuo, is muchmore active as a pain reliever
than D-(+)-THP [67]. Hong et al. compared the effects of
pharmaceutical grade rac-THP on rats with naturally occurring
THP in plant extracts. Stereoselectivity was three times higher
for the (-) than (+) THP; interestingly, rats exposed to mixed
plant extracts containing THP had significantly higher values
for (+)-THP suggesting that stereoselectivity is decreased as
the chemical complexity increases [69]. This study underlines
that the chemical complexity of herbal remedies has a different
effect on pharmacokinetics than the purified known active
ingredient. Likewise, the complexity of kava has often been
argued, by traditional practitioners, to increase the efficacy and
safety of this herbal supplement, and this is the first study to
establish a potential mechanism for this hypothesis.
6.4. Kava strains and variability in manufacturing/preparation
Other potential causes, as suggested by traditional practi-
tioners, of kava toxicity in non-traditional preparations are:
(1) the use of leaves, stems and other plant parts in manufactur-
ing caplets and tinctures instead of rootmaterial, and (2) the use
of inappropriate cultivars in a manner uninformed by cultural
experience and practice. Variances in the chemical composition
between the roots, rhizomes and basal stems of the kava plant
have been of concern. The alkaloid pipermethystine, a cytotoxin,
has been isolated from aerial parts of the plant [27]. Six different
potential products from the plant: roots, stems, basal stems,
peelings and chips from the rhizome and residues, each
traditionally having a specific definition and designated
medicinal uses. It is important that nutraceutical manufac-
turers and novice kava users understand these differences.
Pacific traditional drinkers of kava use only the peeled root,
carefully washed and ground. In contrast, commercial kava
products are often made from peelings and chips of the dried
rhizome contaminated with basal stems in the interests
of economy. A code for standardization has been explicitly
proposed by Teschke et al. [70].
Traditional practitioners also have a sense of the most
appropriate cultivars for specific uses. There are 200 known
kava cultivars in four classifications: Noble, medicinal, Tu Dei
(or Two Days) and Wichmannii cultivars. Noble cultivars areconsidered by Pacific practitioners as the safest as no incidences
of liver toxicity has been linked to their traditional social use. Tu
Dei cultivars are known for their extended psychotropic effects
lasting “two days,” hence their name; these cultivars have been
associated with nausea, which is believed to be caused by a high
concentration of dihydromethysticin. Finally, Piper wichmannii,
the wild species from which the domesticated P. methysticum is
derived, is not used for daily consumption due to its long lasting
physical effects and low degree of beneficial effects. Supplement
manufacturers and their regulators may not take into account
the various cultivar classifications and their different effects.
World Health Organization findings alluded to this as a potential
cause of liver toxicity and the Secretariat of the Pacific Com-
munity expressed the importance of selecting the proper kava
cultivar for export and establishing a set of standards to ensure
the best possible kava to be used for nutraceuticals [47]. Notably,
it may be that kava in Hawai`i is free of toxic effects because it
represents the end-point of the cultivar selection process across
the whole Pacific, so there are no Wichmannii or two day kavas
among theHawaiian varieties [48,71,72]. Thirteen contemporary
cultivars found in Hawai`i are unique to Hawai`i, reflecting a
process of selection and strain development that Hawaiian
farmers engaged in after bringing cultivars from theMarquesas
and through somatic mutation developed/selected the cultivars
we have today on the basis of stem color and effect (Fig. 2)
[48,71,72].
7. Beneﬁts of kava consumption
Kava has beenused in Europe since the 1880s to relieve stress
and anxiety and British herbal practitioners have been using it to
treat urinary cystitis, rheumatism, urethritis and urinary tract
infections since the early 1900s [5,73–75]. Kava has a history of
use as a nervine treating dizziness, melancholy and neuralgia
[74]. More recently, there has been an increased use of kava
to treat disorders such as anxiety, nervous tension, restlessness,
insomnia and even mild depression and symptoms of meno-
pause [76–92]. Trials of kava have demonstrated it to be superior
in treating anxiety compared to placebos and has even been
effective where other medications have not [93]. Additionally,
kava does not appear to be addictive like alcohol and many
prescription drugs; in addition, there is no association with
violent or antisocial behavior and kava use [75,94].
7.1. Beneﬁts suggested by the traditional Paciﬁc pharmacopeia
Kava, at first glance, has a surprisingly broad indigenous
pharmacology. Medicinally, kava has been used for a wide
range of both CNS-centered and peripheral effects. The CNS-
centered effects of kava are the most highlighted both in
traditional practice, recreational use and contemporary
nutraceutical marketing campaigns. These are the sedative
and calming effects, which, in the world of nutraceuticals are
promoted as treatments for stress, anxiety, and depression,
often portrayed as “natural” analogs of anxiolytic and antide-
pressant pharmaceuticals. While the CNS-centered effects are
the most widely cited and discussed, much of the broad list of
traditional medicinal uses is not related to the CNS-centered
effects. Peripherally, `awa is indicated in traditional Pacific
medicine for urogenital conditions (gonorrhea infections, chron-
ic cystitis, difficulty urinating), reproductive andwomen's health
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delivery, to stimulate milk production, as an abortifacient and
contraceptive), gastrointestinal upsets, respiratory ailments
(asthma, coughs, and tuberculosis), skin diseases and topical
wounds, and as an analgesic, with significant subtlety and
nuance attending the precise strain, plant component (leaf,
stem, root, etc.) and preparative method to be used [1–4,75].
These data suggest active components in kava that extend
beyond the GABA-ergic, CNS-active, kavalactones, and that may
be sufficiently varying with strain, component and preparative
method to underlie the complexity that is present in the
traditional pharmacopeia.
7.2. Potential chemopreventive actions of Kava
In spite of the evidence that suggests that kava consumption
is linked to hepatoxicity and tumorigenesis, other studies show
kava as a potential chemopreventive. Dosing of a small number
of mice with 10mg/g of kava for 30 weeks showed a reduction
in chemically-induced lung adenomas by over 50% [95,96].
These studies saw no liver toxicity due to kava exposure. The
flavokawains A, B and C (FKA, FKB, FKC)were tested as possible
kava components responsible for the tumor suppression.
Flavokawains are chalcones, several of which have exhibited
activity against a range of different types of cancers. Of the
three, only FKB demonstrated any reduction in lung adenomas
(34%) [96]. For example, Wattenberg et al. (1994) showed that
2-hydroxychalcone administered at a dose of 5 mg/g reduced
lung tumor multiplicity by approximately 30 to 40 percent.
Moreover, Zi et al. (2005) noted that flavokawain A suppressed
tumor growth in bladder cells [52].Fig. 2. Hawaiian cultivars of Piper methysticum illustrating stem and leaf characteristics
Photography credits: Mr. Ed Johnston, (upper panels) Mr. Harry Brevoort (lower paneSeveral potential mechanisms of anti-carcinogenic activity
were explored in the above studies. First, Proliferating Cell
Nuclear Antigen (PCNA) levels were assessed as PCNA overex-
pression associates with transformation. Substantial increases in
PCNA were observed in kava-exposed animals compared to
controls [95]. Moreover, data on PCNA and Ki67 expression
showed that anti-carcinogenic activity diminishes over time
without continued kava treatment [96]. Caspase 3 upregulation
and increased cleavage of poly ADP-ribose polymerase (PARP)
were also noted in lung tumors from kava-treated mice,
suggesting higher levels of apoptosis.
Another possible mechanism for the chemopreventive effect
of kava is reduction in inducedDNAdamage. After normalization
of DNA adduct abundance for the time-controlled group
experiment, all six NNK-exposed, kava-fed groups exhibited
reduction in all four DNA adducts with 7-pobG, O2-pobdT, and
O6-prodG showing reductions between 30 and 40%; whereas,
O6-mG demonstrated a 70 to 80% reduction. More importantly,
the relative abundances of these four DNA adducts showed no
differences at different time points after NNK exposure, leading
to the idea that kava treatment inhibits DNA damage [97].
8. Conclusions and open questions
A comprehensive understanding of `awa chemistry is
of importance in assessing the future of kava exposure in
both Pacific and global populations. This generates two key
considerations. First, the type of extraction to be character-
ized has important implications. There is a tension between
fidelity to the traditional aqueous extractions of primarily
root samples, and the need to analyze organic extracts ofused in traditional selection practices. Hawaiian names of cultivars are shown.
ls), Association for Hawaiian `Awa, Hilo, Hawai`i.
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of commercialized `awa. There is good evidence that kava
toxicity and efficacy are linked to extractionmethod. Since both
traditional and commercial/organic extracts are public health
issues, both need to be examined comprehensively.
8.1. Is kava toxic?
Despite the link to kava and liver toxicity demonstrated
in vivo and in vitro, in the history ofWestern kava use, toxicity is
still considered relatively rare. Only a fraction of the handful of
cases reviewed for liver toxicity could be, with any certainty,
linked to kava consumption andmost of those involved the co-
ingestion of othermedications/supplements [8,57]. Thatmeans
that the incident rate of liver toxicity due to kava is one in 60-
125 million patients [12]. For Pacific traditional users, despite
the much higher kavalactone exposure, `awa liver toxicity is
either unheard of or unreported. Nevertheless, in rural areas of
the Pacific, where hepatitis is endemic, liver disease that may
be caused by kava consumption may be masked and reported
as other causes [9]. It is difficult to say with any sense of
accuracy since there is a shortage of epidemiology and public
health data in Pacific populations who habitually use kava.
8.2. Beyond the kavalactones—is there an entourage effect in
kava?
Kava plants are likely to contain a diverse secondary
metabolome, with hundreds of compounds that can impact
the physiological responses of human cells and tissues
[27,28,98–100]. The focus of the `awa field upon the
kavalactones is linked to the strong likelihood that these
compounds' ligation of CNS GABA receptors is responsible
for the relaxant and anxiolytic effects of the drink and its
supplements [101,102]. However, the physiological (and possi-
bly pathophysiological) effects of kava may be underestimated
by a unilateral focus upon the kavalactones. The secondary
metabolome of Cannabis sativa provides an analogy here. For
decades the primary focus of the field, the marijuana growing
community, and medicinal marijuana proponents has been on
the major cannabinoid compounds Δ9-THC, cannabidiol and
cannabinol. These are indeed themain CNS-active components
but they and their derivatives comprise ~7 of the N400 known
bioactive molecules in C. sativa. Indeed, until the so-called
‘entourage’ of terpenes, alkaloids, etc., was factored into
cannabinoid pharmacology [103,104], our understanding of
its mechanisms and breadth of effect was severely limited.
Similarly, the `awa field may now benefit from examination
of the P. methysticum ‘entourage’.
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